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ABSTRACT 
 
DNA DOUBLE STRAND BREAKS SUPPRESS EXPRESSION OF THE RAG RECOMBINASE: 
MECHANISMS AND CONSEQUENCES 
Megan R. Fisher 
Craig H. Bassing 
Developing B and T lymphocytes must rearrange the genomic sequence of antigen 
receptor genes by V(D)J recombination. The lymphocyte-specific endonuclease RAG, 
composed of Rag1 and Rag2, initiates this process by cleaving specific sites within 
antigen receptor loci. RAG expression must be carefully regulated to ensure that V(D)J 
recombination occurs only under appropriate circumstances. The Bassing laboratory has 
previously demonstrated that Igκ locus cleavage by RAG in pre-B cells initiates a 
feedback-inhibition signal suppressing RAG expression. Here, we show that DNA double 
strand breaks (DSBs) induced by a variety of genotoxic agents have a similar effect in 
suppressing mRNA expression of Rag1 and Rag2. This effect can be observed in pro-B 
cells, pre-B cells, and DN thymocytes, but is not found in DP thymocytes. Using primary 
pre-B cells as a model system, we show that DSBs activate ATM and Nemo to rapidly 
suppress transcription of Rag1 and Rag2. In pre-B cells, loss of Rag1 and Rag2 mRNA 
expression leads to loss of Rag1 protein, but Rag2 protein is more stable and persists in 
the absence of Rag2 mRNA. Suppression of Rag1 expression by DSBs is associated with 
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suppressed RAG-mediated cleavage of the Igκ locus or an artificial recombination 
substrate in Abelson-transformed pre-B cells. However, simply over-expressing Rag1 
does not allow cells to complete V(D)J recombination in the presence of DSBs, 
suggesting that other factors may also play a role in suppressing V(D)J recombination. 
Parallel studies indicate that that RAG-induced DSBs created during V(D)J recombination 
activate this suppressive signal to enforce allelic exclusion of IgH, TCRβ, and Igκ antigen 
receptor proteins. We discuss the importance of Rag1 and Rag2 suppression in the 
context of allelic exclusion and propose a role in maintaining genomic stability of 
developing B and T lymphocytes. 
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Chapter 1: Introduction  
Requirements of the Immune System 
 All organisms must recognize and react to foreign species that may attempt to 
colonize them. In many cases the colonizing species may harm or even kill its host, such 
as the wide variety of pathogens that cause diseases ranging from the common cold to 
smallpox. In other cases, the relationship between host and colonizer is innocuous or 
even mutually beneficial, as in the case of the human digestive tract, which relies on a 
variety of resident bacteria to help break down food into nutrients that human cells can 
metabolize (Quigley, 2013). An immune system must distinguish between components 
of the organism (self) and foreign entities (non-self) and neutralize potentially 
dangerous invaders while minimizing damage to the organism itself and tolerating 
foreign organisms that benefit their host.  
 Immune systems employ a wide variety of methods to detect non-self organisms 
and determine how to respond to them. Components of the immune system are 
traditionally categorized as "innate" or "adaptive" depending on how specific the 
response is to a particular stimulus. Innate immune responses are activated when cells 
recognize characteristic components of a particular class of pathogens, and activate a 
response targeted to that kind of pathogen. For example, cell-surface receptors that 
recognize chemicals in the bacterial cell wall would activate an anti-bacterial response if 
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they detect bacteria where there should be no bacteria. Similarly, intracellular receptors 
can detect viral DNA or RNA in a host cell's cytoplasm and activate an anti-viral 
response. Innate immune responses allow rapid responses to pathogens that an 
organism is pre-programmed to recognize (Brubaker et al., 2015). 
 However for humans and many other species, innate immunity alone cannot 
protect the organism from the wide variety of pathogens encountered in daily life 
(Fischer, 2000). Adaptive immunity allows an organism to recognize unique features of a 
particular foreign substance, known as antigens. In concert with innate immune 
components, adaptive immunity allows highly specific, effective responses targeted to 
particular pathogens (Bonilla and Oettgen, 2010). In humans and other jawed 
vertebrates, the huge variety of antigen receptors required for adaptive immunity is 
generated by the process of V(D)J recombination, in which developing B and T 
lymphocytes rearrange parts of their antigen receptor genes to create unique receptors 
(Brack et al., 1978; Hedrick et al., 1984a). This process allows each new B or T cell to 
recognize a different, almost random antigen, so that the full repertoire of B and T cells 
is capable of recognizing a vast array of unknown antigens with high specificity. Because 
this process is largely random, many of the receptors produced are autoreactive, 
meaning they bind to components of the host organism and could theoretically initiate 
an immune response to the organism itself. Developing lymphocytes must pass through 
several selection steps that either cause autoreactive lymphocytes to die or otherwise 
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prevent them from being activated by their cognate antigen. Failure of these selection 
steps can lead to autoimmune diseases or immunodeficiencies (von Boehmer and 
Melchers, 2010). 
Basic Mechanisms of V(D)J recombination 
 There are several antigen receptor loci capable of undergoing V(D)J 
recombination in mammals. In general these loci are composed of many variable (V) 
segments and several joining (J) segments. Certain loci also have several diversity (D) 
segments located between the V and J segments. In addition to these segments that 
encode the variable antigen-recognition sections of an antigen receptor, constant 
regions (C) encode non-variable regions of the receptor necessary for signaling 
(Tonegawa, 1983; Hedrick et al., 1984b). Before rearrangement V, D, and J segments 
span a genomic distance of up to 2.5 megabases. Each of these V, D, and J segments are 
flanked by recombination signal sequences (RSSs) (Sakano et al., 1979). RSSs are 
composed of three components. Directly adjacent to the antigen receptor gene segment 
is a highly conserved seven base-pair heptamer. Next to the heptamer is a poorly-
conserved spacer of either 12 or 23 base pairs, followed by a conserved nonamer. An 
endonuclease complex composed of Rag1 and Rag2 (RAG) binds to and cleaves at RSSs 
adjacent to two different gene segments, creating a DNA double-strand break (DSB) 
directly adjacent to each segment (McBlane et al., 1995). Processing of these breaks can 
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lead to loss and/or addition of several nucleotides at the break site. Finally, non-
homologous end joining (NHEJ) factors rearrange and repair the DSBs so that the two 
selected gene segments are directly adjacent to each other in the repaired DNA 
sequence (Helmink and Sleckman, 2012). This may be accomplished by removing 
intervening DNA if the selected DNA segments were in the same orientation in the 
germline DNA (rearrangement by deletion; Figure 1.1). Alternatively, if the two gene 
segments were originally in opposite orientations, a section of DNA ending with one of 
the segments is flipped to bring the two selected segments into proximity 
(rearrangement by inversion). In either case, the repairs are made such that one repair 
site includes both gene segments (a coding join) and the other repair site includes both 
RSSs (a signal join) (Helmink and Sleckman, 2012). 
 Generally speaking, lymphocytes attempt rearrangement of only one antigen 
receptor locus at a time (Chan et al., 2013; Chaumeil et al., 2013; Hewitt et al., 2009). 
However, if an initial rearrangement is non-functional, the cell may subsequently 
attempt to rearrange the homologous antigen receptor allele, or create additional 
rearrangements on the first allele. Because nucleotides can be randomly added to or 
removed from the coding ends of the DSB intermediates, two-thirds of all 
rearrangements are out-of-frame and therefore non-functional. Inclusion of a stop 
codon or use of a pseudogene segment in the rearrangement can also produce non-
functional antigen receptor genes (Helmink and Sleckman, 2012). Only a functionally 
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rearranged antigen receptor gene that can produce a protein product expressed on the 
cell surface can promote lymphocyte survival and development (Miosge and Goodnow, 
2005).  
 At each stage of lymphocyte development, the expression of the V(D)J catalyst 
(RAG) and the accessibility of the substrate (antigen receptor genes) are each carefully 
regulated to ensure that the appropriate genes are rearranged at the appropriate time. 
Antigen receptor genes must be prepared for rearrangement in the appropriate 
developmental stage by undergoing a process of histone modification, precise 
nucleosome positioning, and DNA-looping to bring distant gene segments into close 
proximity (Proudhon et al., 2015). Similarly, RAG expression is strictly limited to B and T 
cells at appropriate developmental stages (Nagaoka et al., 2000). Different transcription 
factors and cis-regulatory elements drive Rag1 and Rag2 expression in developing B and 
T cells, but in both cell types rearrangement and subsequent cell surface protein 
expression of the appropriate antigen receptor gene suppresses further transcription of 
Rag1 and Rag2 (Nagaoka et al., 2000).  
An overview of B and T lymphocyte development 
 V(D)J recombination is absolutely required for B and T cell development, as 
failure to produce a functional antigen receptor leads to complete developmental arrest 
of lymphocyte progenitors (Mombaerts et al., 1992a; Shinkai et al., 1992). Lymphocyte 
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development itself is a complex process in which cells progressively commit to a specific 
developmental pathway. Transcription factor networks must guide cells down different 
pathways while integrating environmental cues such as availability of cytokines (Lin et 
al., 2010). Within this context, V(D)J recombination is regulated to promote the creation 
of functional antigen receptor genes at the appropriate stages of lymphocyte 
development (Fig. 1.2).  
 Both B and T cells develop from a common precursor. Commitment to the B 
lymphocyte lineage requires a number of transcription factors including Ikaros, E2A, 
early B-cell factor (EBF1), and Pax-5 (Lin et al., 2010). Among other important functions, 
many of these factors regulate V(D)J recombination in pro-and pre-B cells (Hsu et al., 
2003; Reynaud et al., 2008). These factors are important both for inducing or 
suppressing expression of the RAG recombinase and for preparing specific antigen 
receptor loci for recombination. 
 Pro-B cells first rearrange one Immunoglobulin Heavy Chain (IgH) gene (Alt et al., 
1984). An in-frame, functional rearrangement leads to cell surface of the pre-B cell 
receptor (pre-BCR), composed of the newly produced IgH chain in complex with the 
invariant surrogate light chains. The pre-BCR sends signals that inhibit further IgH 
rearrangement and trigger proliferation and progression to the pre-B cell stage 
(Übelhart et al., 2015). If the first IgH rearrangement is non-functional, the cell will 
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attempt to rearrange the second IgH allele; if this second attempt creates a productive 
IgH gene then development proceeds, but if it is unproductive the cell dies. Cells that do 
proceed to the pre-B cell stage eventually cease proliferating, and begin to rearrange 
the light chain genes, Igκ and then Igλ (Coffman and Weissman, 1983). Like at the pro-B 
cell stage, failure to produce a functional light chain gene leads to cell death. Creation of 
a functional light chain capable of binding to IgH and allowing cell surface expression of 
a BCR prevents further recombination and causes progression to the immature B cell 
stage (Melchers et al., 1995). The antigen-recognition portion of the BCR is a 
heterotetramer containing two IgH chains and two IgL (either Igκ or Igλ) chains (Pleiman 
et al., 1994). Immature B cells expressing a BCR that recognizes self-antigens may 
undergo receptor editing, in which they further rearrange their light chain genes in an 
attempt to produce a non-autoreactive BCR (Gay et al., 1993; Tiegs et al., 1993). 
 Developing T cells go through a similar process in which CD4 CD8 double 
negative (DN) thymocytes rearrange the T Cell Receptor β (TCRβ) gene or TCRγ and 
TCRδ genes. Formation of a complete γδTCR leads to γδT cell development, while 
functional rearrangement of TCRβ promotes progression to the CD4 CD8 double positive 
(DP) thymocyte stage (Mombaerts et al., 1992b; Xiong and Raulet, 2007). DP 
thymocytes continuously rearrange TCRα genes until they produce a functional alpha 
chain capable of binding the TCRβ chain and allowing cell surface expression and 
signaling of the αβTCR by weakly binding MHC presented on thymic epithelial cells 
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(Mombaerts et al., 1992b; Klein et al., 2014). Failure to create a functional αβTCR leads 
to "death by neglect", while DP thymocytes expressing a receptor that activates 
relatively strong signaling may either die or become regulatory T cells that suppress 
immune activation (Jordan et al., 2000, 2001; Apostolou et al., 2002) 
Allelic exclusion in lymphocytes 
 As with all autosomal genes, cells contain two alleles of each antigen receptor 
gene. If nothing prevented the expression of multiple receptor chains within the same 
cell, we would expect these two alleles to rearrange and produce unique antigen 
receptor chains, leading to expression of multiple antigen receptors on the cell surface. 
The most extreme case would be a B cell that productively rearranged both IgH, both 
Igκ, and all Igλ alleles; because an individual receptor contains two IgH and two IgL 
chains, this cell could express receptors including dozens of combinations of IgH and IgL 
chains on its cell surface. However, it has long been recognized that this is not the case; 
instead, most antigen receptor chains are "allelically excluded", meaning an individual 
cell expresses protein from only one allele. Most B cells express one IgH and IgL chain 
(Cebra et al., 1966; Pernis et al., 1965). Most T cells express one TCRβ chain, although 
TCRα is an exception and does not seem to be allelically excluded (Casanova et al., 1991; 
Padovan et al., 1993). It is important to note that allelic exclusion was originally defined 
by cell surface expression of a single antigen receptor . Later, it was found that allelic 
9 
 
exclusion is frequently enforced at the level of gene rearrangement, as lymphocytes 
usually contain only one productive rearrangement for each antigen receptor chain (Alt 
et al., 1984; Casanova et al., 1991). However, a cell that is "included" at the genetic 
rearrangement level may still "exclude" at the level of cell surface receptor expression, 
as several factors may prevent an apparently functional antigen receptor chain from 
being expressed on the cell surface (ten Boekel et al., 1998; Sant’Angelo et al., 2001; 
Steinel et al., 2010).  
 Although allelic exclusion of antigen receptors was discovered over 50 years ago, 
it is still unclear why it is enforced. An allelically included lymphocyte would express 
receptors with different specificities on its cell surface. One potential disadvantage of 
this situation would be inefficient negative selection of allelically included cells 
expressing both a self-reactive receptor and an innocuous receptor. Studies utilizing 
transgenic expression of self-reactive antigen receptors show that this is technically 
possible, but while the "autoreactive cells" can be stimulated by self antigen ex vivo 
(Iliev et al., 1994; Zal et al., 1996), only one study reported autoimmune disease 
resulting from these cells (Sarukhan et al., 1998). However these studies are limited by 
the extreme skewing to a single autoreactive receptor, a situation that is not reflective 
of the diverse antigen receptor repertoire found in healthy individuals. At the same 
time, it must be recognized that normal individuals do have many allelically included 
cells, which generally do not harm that individual. Attempting to address this fact, 
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certain studies have investigated the autoreactive potential of naturally occurring 
allelically included lymphocytes. Two groups studying different strains of lupus-prone 
mice came to conflicting conclusions regarding the ability of dual-reactive B cells to 
promote autoimmunity; it was suggested that differences in tolerance checkpoints 
between the two models might affect the degree to which allelically included B cells are 
activated and mediate disease (Fournier et al., 2012; Makdasi and Eilat, 2013). A study 
examining B cells from healthy mice found that cells expressing two Igκ chains were 
more likely than single expressers to produce anti-nuclear reactive antibodies, a 
common screen for self-reactivity (Casellas et al., 2007). More recently, it was found 
that preventing the normal allelic inclusion of TCRα by deleting one TCRα constant 
region allele reduced the frequency of T cells responding to an auto-antigen (Ni et al., 
2014). While these results suggest that allelically included cells may be overrepresented 
in the pool of self-reactive lymphocytes, they also highlight the fact that peripheral 
tolerance mechanisms are usually sufficient to restrain the autoreactive potential of 
either allelically excluded or included lymphocytes. However, it is possible that normal 
allelic exclusion represents a "good enough" situation which prevents other tolerance 
mechanisms from being overwhelmed, and that loss of allelic exclusion might disrupt 
this balance. 
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DSBs and allelic exclusion 
 During Igκ recombination in pre-B cells, RAG-mediated DSBs at one Igκ allele 
activate the DNA damage response protein Ataxia Telangiectasia Mutated (ATM) to 
prevent cleavage of the second allele (Steinel et al., 2013). ATM deficiency allows 
simultaneous rearrangement of Igκ alleles; in this context, the frequency of B cells 
expressing two unique Igκ chains approximately doubles. These results suggest that 
monoallelic rearrangement enforced by ATM activation is an important factor in allelic 
exclusion of Igκ. As described in Chapter 4 of this work, we show that ATM deficient B 
cells also have increased inclusion of the IgH chain, and ATM deficient T cells have 
increased inclusion of TCRβ, suggesting that a similar mechanism operates in pro-B cells 
and DN thymocytes. 
Different genetic elements regulate Rag transcription during B and T cell development 
 Early in the search for Rag1 and Rag2 promoters and enhancers, two general 
themes emerged. One, it was found that Rag1 and Rag2 are generally co-expressed (Yu 
et al., 1999). This is unsurprising, as the two genes are located in close proximity and 
could easily be regulated by the same genetic elements. Secondly, it quickly became 
clear that different sites are important for Rag expression in developing B vs. T cells, and 
in some cases DN vs. DP thymocytes (Monroe et al., 1999; Yu et al., 1999; Wei et al., 
2002). A schematic of the Rag1/Rag2 gene locus with known genetic regulatory 
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elements and trans-acting factors is shown in Fig. 1.3. As discussed below, promoter 
binding sites for different transcription factors are required in B vs. T cells, and only a 
few factors have been shown to bind in both B and T cells. In all cases, enhancer 
elements are required for efficient Rag1 and Rag2 expression in vivo. Developing B cells 
and DP thymocytes seem to use two entirely distinct sets of enhancers to drive Rag1 
and Rag2 transcription, while DN thymocytes use enhancers from each set. 
 The Rag1 promoter was the first element identified. Interestingly, in luciferase 
assays it can drive limited transcription in mature lymphocyte lines and non-lymphoid 
cells, in contrast to the restricted pattern of endogenous Rag1 mRNA expression (Brown 
et al., 1997; Fuller and Storb, 1997). This may be partially due to the fact that the 
widely-expressed transcription facto NF-Y seems to be involved in Rag1 promoter 
activity (Brown et al., 1997; Fuller and Storb, 1997). Therefore, it is believed that 
endogenous Rag1 transcription must require enhancer elements that are only active in 
developing lymphocytes. In contrast to the Rag1 promoter, Rag2 promoter activity 
seems to be intrinsically limited to developing B and T cells (Lauring and Schlissel, 1999; 
Kishi et al., 2000; Fong et al., 2000). This might be due to a requirement for B and/or T 
cell restricted transcription factors for promoter activity.  
 In addition to their promoters, Rag1 and Rag2 transcription is affected by a 
variety of enhancer elements, and all of these elements are preferentially active in 
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either B or T cells. Four enhancers, all located 5' of the Rag2 gene, and one silencer 
element located between the Rag1 and Rag2 genes have been identified. Two of these 
elements, the Ep and Erag enhancers, demonstrate activity only in developing B cells 
(Hsu et al., 2003; Wei et al., 2005). The D3 enhancer (also called Ed) is active in pro-B 
and pre-B cells and in DN thymocytes (Wei et al., 2002). Finally the anti-silencer element 
(ASE) required to overcome the effect of an active intergenic silencer is absolutely 
required for Rag1 and Rag2 expression in DP thymocytes, is partially responsible for 
expression in DN thymocytes, but seems to play no role in Rag1 and Rag2 expression in 
developing B cells (Yannoutsos et al., 2004).  
 The Erag enhancer is located approximately 22kb 5' of the first Rag2 exon (Hsu 
et al., 2003). Mutation of the endogenous Erag enhancer decreases Rag1 and Rag2 
mRNA expression in pro-B, pre-B, and immature B cells, leading to decreased B cell 
development; however this mutation has no effect on thymocyte development or Rag1 
and Rag2 expression in either DN or DP thymocytes (Hsu et al., 2003). Erag is also 
important for Rag1 and Rag2 expression at the earlier common lymphocyte progenitor 
(CLP) stage of development (Borghesi et al., 2005). 
 The Ep enhancer is the most proximal enhancer to the Rag1 and Rag2 genes, 
located approximately 2.6 kb 5' of the first Rag2 exon. Ep was identified as one of three 
DNase-hypersensitive sites found in lymphocyte cell lines upstream of the Rag2 gene 
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(Wei et al., 2002). The effect of the Ep enhancer on endogenous Rag1 and Rag2 
transcription has not been tested, but a transgenic construct containing GFP under the 
control of the Rag2 promoter and Ep was shown to drive GFP expression in both B220+ 
IgM- and B220+ IgM+ bone marrow cells, corresponding to pro- and pre-B cells vs. 
immature and mature B cells (Wei et al., 2005). GFP expression was also found in B220+ 
splenic B cells, which do not normally express Rag1 and Rag2, suggesting that a third 
factor normally blocks Ep-driven transcription in these cells (Wei et al., 2005). 
 The Ed (or D3) enhancer was identified in the same DNase-hypersensitivity 
screen as the Ep enhancer. It is located approximately 8 kb 5' of the Rag2 gene. Unlike 
Ep, Ed promotes Rag2 promoter activity in both developing B cells and in DN 
thymocytes, but has no activity in mature lymphocytes (Wei et al., 2002).  
 The anti-silencer element (ASE) is the only enhancer-like element known to 
affect Rag1 and Rag2 expression in DP thymocytes. It is also the most distant element, 
located between 71 and 86 kb 5' of the Rag2 gene (Yannoutsos et al., 2004). It acts by 
overcoming the effects of the intergenic silencer element located between the Rag1 and 
Rag2 genes (Yannoutsos et al., 2004). In ASE knock-out mice, the silencer element 
almost completely prevents Rag1 and Rag2 expression in DP thymocytes. Absence of 
the ASE also decreases Rag1 and Rag2 expression in DN thymocytes, although less 
drastically. Experiments using GFP-reporter constructs showed that the silencer does 
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not prevent Rag expression in developing B cells (Yannoutsos et al., 2004; Yu et al., 
1999).  
Transcription factors bind that Rag1 and Rag2 gene regulatory elements 
 Just as different genetic elements drive Rag1 and Rag2 transcription in 
developing B and T cells, the transcription factors that bind to these elements are 
mostly distinct between the two lineages. A comprehensive list of the many factors 
known to bind the Rag1/Rag2 gene locus is provided in Fig. 1.3. Unfortunately these 
factors have been identified in a fairly piecemeal fashion, and so it is difficult to draw a 
coherent picture of their relative importance in normal developing lymphocytes. Early 
experiments mostly relied on EMSA to show that factors can bind Rag1 and Rag2 
regulatory sequences in vitro; more recently ChIP has been used to show that some of 
these factors actually do bind these regulatory sequences in vivo. In most cases, 
luciferase experiments showed that individual factors have the potential to promote (or 
in a few cases inhibit) Rag1 and Rag2 transcription. However knock-out mouse models 
of these factors often show no effect on Rag1 and Rag2 mRNA expression, or may even 
show the opposite effect of what was predicted by luciferase experiments. The 
following sections will briefly summarize the findings for several factors that have been 
implicated in regulating Rag1 and Rag2 expression in either developing B or T cells, or in 
both. 
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 Many of the factors shown to bind the Rag1/Rag2 gene locus in developing B 
cells are critical for B cell development in general, including Pax-5, E2A, Ikaros, Bcl11a, 
and Foxo1 (Bain et al., 1994; Nutt et al., 1997; Dengler et al., 2008; Reynaud et al., 2008; 
Lee et al., 2013). All have been shown to promote Rag1 and/or Rag2 transcription in 
luciferase assays (Amin and Schlissel, 2008; Fuller and Storb, 1997; Hsu et al., 2003; 
Lauring and Schlissel, 1999; Lee et al., 2013); however knockouts of these factors 
produce a variety of results. Pax-5 knockout pro-B cells apparently have normal Rag1 
and Rag2 expression, although their development is arrested due to other defects (Nutt 
et al., 1997). E2A knockout fetal liver was shown to lack Rag1 and Rag2 expression, 
although this might be because few cells developed to stages where Rag expression is 
expected to by high (Bain et al., 1994); another paper showed that an E2A knockout pre-
B cell line expressed normal levels of Rag1 and Rag2 mRNA (Lazorchak et al., 2006). On 
the other hand, Rag1 and Rag2 mRNA expression is impaired in Foxo1, Ikaros, and 
Bcl11a knockouts, suggesting that these factors are more crucial for Rag1 and Rag2 
expression (Dengler et al., 2008; Reynaud et al., 2008; Lee et al., 2013). Complicating 
matters, several of these factors can also regulate the expression of other factors 
involved in Rag1 and Rag2 transcription. For example, both Ikaros and Bcl11a can 
regulate Foxo1 expression, and so their impact may not entirely be direct (Ferreirós-
Vidal et al., 2013; Lee et al., 2013) Ikaros can also suppress expression of the only known 
17 
 
factor that directly inhibits Rag1 and Rag2 transcription in B cells, Gfi1b (Schulz et al., 
2012; Ferreirós-Vidal et al., 2013). 
 When studies examining Rag1 and Rag2 transcription differentiate between pro- 
and pre-B cells, they often find little difference between the two stages. In contrast, 
there are several differences between DN and DP thymocytes. The Ed enhancer can 
drive reporter gene expression in DN but not DP thymocytes, and transcription factor 
C/EBP can increase Ed activity in luciferase assays (Wei et al., 2002). Active NFAT 
appears to suppress Rag1 and Rag2 expression by binding to several sites within the 
locus in DN cells, but an effect in DPs has not been reported (Patra et al., 2006). In DP 
thymocytes, the ASE is critical for Rag1 and Rag2 expression, but it is less important in 
DN thymocytes. The ASE is required to overcome the effects of the intergenic silencer, 
whose effects are believed to be mediated by Runx (Yannoutsos et al., 2004). The 
protein SATB1, which can be involved in attaching DNA to the nuclear matrix and in 
forming loops between DNA regions, is required to bring the ASE and the Rag1 and 
Rag2 promoters into close proximity. SATB1-deficiency reduces Rag1 and Rag2 
expression in DP but not DN thymocytes, although not quite as drastically as ASE 
deletion (Hao et al., 2015; Yannoutsos et al., 2004). 
 To date, few factors have been found to bind the Rag1/Rag2 gene locus in both 
B and T lineage cells: Sp1 (Miranda et al., 2002), NF-Y (Brown et al., 1997; Fuller and 
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Storb, 1997), Lef-1 (Okamura et al., 1998; Jin et al., 2002), and c-myb (Fong et al., 2000; 
Wang et al., 2000; Kishi, 2002; Miranda et al., 2002). However none of these factors 
have been reported to be essential for Rag1 and Rag2 expression in either B or T cells. 
Sp1 is a ubiquitously expressed transcription factor that may increase the effectiveness 
of lymphocyte-specific factor in activating Rag1 and Rag2 transcription (Miranda et al., 
2002). NF-Y is active in many tissues and can drive Rag1 promoter activity in luciferase 
assays using developing B or T cell lines (Brown et al., 1997; Fuller and Storb, 1997). 
However its effect on endogenous Rag1 expression has not been reported. Lef-1 
knockout thymocytes also express Rag1, although this may be due to a compensatory 
effect of TCR-1; ex vivo cultured double knock-out thymocytes express only low levels of 
Rag1 mRNA. However they are also largely arrested at a developmental stage in which 
high Rag1 expression is not expected, making this result difficult to interpret (Okamura 
et al., 1998). Finally, c-myb overexpression was actually shown to decrease Rag1 and 
Rag2 mRNA expression, although the effect is likely indirect (Timblin and Schlissel, 
2013). 
 As shown above, many factors have been identified that bind to the Rag1/Rag2 
gene locus and seem to regulate its activity. Many of the factors that apparently have 
the ability to promote Rag1 and Rag2 transcription as measured by luciferase assays do 
not actually seem required to do so in developing lymphocytes. This may be due to 
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compensation between factors, so that most transcription factors that bind the 
Rag1/Rag2 gene locus and promote transcription are not absolutely essential. 
Signaling pathways that regulate Rag expression: PI3K-Akt-Foxo1 
 One of the most critical direct regulators of Rag1 and Rag2 transcription in 
developing B cells seems to be Foxo1. Critical factors for B lineage commitment and 
development, such as Ikaros, E2A, and EBF1 (Reynaud et al., 2008; Lin et al., 2010), 
promote Foxo1 expression. Foxo1 binds to the Erag enhancer in pre-B cells, and Foxo1 
deficient cells have low Rag1 and Rag2 mRNA expression. Foxo proteins are rendered 
transcriptionally inactive and degraded via phosphorylation by Akt (Biggs et al., 1999). 
Accordingly, the activity of Akt and its upstream activator PI3K suppress Rag1 and Rag2 
expression in pre-B cells (Amin and Schlissel, 2008), while PTEN, a negative regulator of 
Akt, promotes Rag1 and Rag2 expression (Alkhatib et al., 2012). As both the pre-BCR 
and BCR activate PI3K, this pathway is believed to be involved in the suppression of 
Rag1 and Rag2 expression upon formation of a productive immunoglobulin heavy chain 
or light chain (Amin and Schlissel, 2008; Werner et al., 2010). 
Signaling pathways that regulate Rag expression: Mapk/Erk 
 Erk signaling has been implicated in suppressing Rag1 and Rag2 expression in 
both developing T and B cells. In Jurkat T cells and thymocytes, it was shown that tonic 
TCR signaling activates the Erk and Abl kinases, which cooperate to suppress Rag1 and 
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Rag2 mRNA expression (Roose et al., 2003). Similarly, in developing B cells it was found 
that either active or tonic signaling from the BCR activates Erk in addition to the Akt 
pathway described above, and that these two pathways cooperate in suppressing Rag1 
and Rag2 transcription factors. In this context, Erk activity reduced E2A binding to the 
Erag enhancer (Novak et al., 2010). 
Signaling pathways that regulate Rag expression: NF-κB 
 NF-κB signaling plays a fundamental role in lymphocyte development, among 
other immune system functions. The family of NF-κB transcription factors includes 5 
members which can form a variety of transcriptionally active of homo- or heterodimers 
(Hayden and Ghosh, 2012). Three of these proteins (RelA/p65, RelB, and c-Rel) contain 
transactivation domains and can promote transcription when bound to a gene locus. 
The other two (NFKB1/p50 and NFKB2/p52) lack transactivation domains, and can only 
promote transcription as part of a heterodimer in which the other partner contains a 
transactivation domain (Hayden and Ghosh, 2012). Although an "NF-κB consensus site" 
has been defined, different dimers may preferentially bind to somewhat different DNA 
sequences (Wong et al., 2011). 
 NF-κB signaling is often generalized as either canonical or non-canonical, 
depending on the activation pathway and the particular dimer pairs activated by the 
signal (Hayden and Ghosh, 2012). Both pathways can be activated by a variety of 
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upstream signaling inputs that converge on the two common pathways. Signals 
activating the canonical pathway lead to phosphorylation of the Inhibitor of nuclear 
factor κB kinase subunit β (IKKβ), which in turn phosphorylates the nuclear factor of 
kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα) (Hayden and 
Ghosh, 2012). IKKβ normally exists in complex with IKKα and the NF-κB essential 
modulator (Nemo), and Nemo expression is absolutely required for IKKβ 
phosphorylation of IκBα and activation of the canonical pathway (Li et al., 1999; 
Rudolph et al., 2000). IκBα normally binds to NF-κB factor complexes (RelA/p50 most 
commonly) and prevents their activity; upon phosphorylation it is degraded and 
RelA/p50 (or other) complexes are free to activate transcription of target genes (Hayden 
and Ghosh, 2012). 
 The non-canonical pathway follows a somewhat similar sequence of events 
requiring different factors. Initial activation depends on stabilization and accumulation 
of the NF-kB inducing kinase (NIK), and so non-canonical signaling acts relatively slowly 
as it requires new protein synthesis (Senftleben et al., 2001). NIK phosphorylates IKKα, 
which in turn phosphorylates p100. Prior to phosphorylation, p100 exists in 
transcriptionally inactive complex with RelB; upon phosphorylation p100 undergoes 
partial proteolytic processing to the active p52 form. The p52/RelB dimer can then 
activate transcription of target genes (Hayden and Ghosh, 2012).  
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 Although both the canonical and non-canonical pathways typically activate gene 
transcription, NF-κB factors can also inhibit transcription of target genes in some 
circumstances. For example p50/p50 or p52/p52 homodimers, lacking transactivation 
domains, can prevent the binding of activating NF-κB complexes (Bohuslav et al., 1998). 
Cofactors such as Bcl-3 can modify the activity of p50/p50 and p52/p52 homodimers; 
complexes containing Bcl-3 can either activate or inhibit transcriptional activation, 
depending on post-translational modifications of the Bcl3 protein (Fujita et al., 1993; 
Dechend et al., 1999; Grundström et al., 2004). 
 Although there are several NF-κB binding sites within the Rag gene locus 
(Verkoczy et al., 2005), the role of NF-κB signaling in regulating Rag expression has been 
controversial; various studies find that NF-κB activity either promotes, represses, or has 
no effect on Rag1 and Rag2 mRNA expression. Studies showing no effect of NF-κB on 
Rag1 and Rag2 expression focused on basal expression in pre-B cells, showing that 
neither Nemo-deficiency nor expression of a dominant-negative IκBα construct affected 
Rag1 or Rag2 mRNA expression (Amin and Schlissel, 2008; Derudder et al., 2009). An 
earlier study implicated NF-κB in promoting Rag1 and Rag2 expression during receptor 
editing in immature B cells (Verkoczy et al., 2005). This study showed that IgM-
crosslinking relieved IκBα-mediated NF-κB inhibition and caused several NF-κB factors to 
bind the Rag gene locus. However, the same study showed that p50 knock-out pre-B 
cells have constitutively high levels of Rag1 and Rag2 mRNA, suggesting that this factor 
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normally suppresses Rag1 and Rag2 expression. More recently, IKK inhibition was 
shown to modestly increase recombination of a reporter substrate in cycling Abelson 
cells without sti-571 treatment, suggesting that NF-κB activity normally suppresses Rag1 
and Rag2 expression (Ochodnicka-Mackovicova et al., 2015).  
Roles of the DNA damage response in V(D)J recombination 
 The DSBs produced during V(D)J recombination activate the conserved DNA 
damage response (DDR), and the signals generated by this pathway are crucial for 
proper recombination and for normal lymphocyte development (Bredemeyer et al., 
2006; Huang et al., 2007; Bredemeyer et al., 2008). The protein kinase ATM plays an 
important role in this response. ATM is activated by DSBs and coordinates a variety of 
downstream signals promote DSB repair, arrest the cell cycle to allow time for repair, 
and promote apoptosis if the DSBs cannot be repaired (Shiloh and Ziv, 2013). Due to 
these crucial functions, humans and mice deficient in ATM expression are predisposed 
to develop a genomic instability leading to cancer (Barlow et al., 1996; Taylor et al., 
1996; Xu et al., 1996). In pre-B cells, ATM regulates the expression of many genes 
important for B cell development, implicating the DDR in developmental processes 
besides V(D)J recombination (Bredemeyer et al., 2008). Although V(D)J recombination 
can occur without ATM, ATM is normally activated by RAG-mediated DSBs and is 
required for their efficient and accurate repair (Bredemeyer et al., 2006). Additionally, 
24 
 
the Bassing laboratory has shown that ATM can mediate feedback inhibition of V(D)J 
recombination, ensuring that only one antigen receptor gene rearranges at a time 
(Steinel et al., 2013). 
 Although it is crucial for lymphocyte development, the deliberate formation of 
DSBs during V(D)J recombination creates a risk of translocation if the process goes awry. 
RAG-mediated DNA cleavage would be particularly risky in the presence of existing DNA 
damage, as the presence of two DSBs in a cell increases the risk of translocation by 
several orders of magnitude (Richardson and Jasin, 2000). Normal cellular metabolism, 
environmental factors, or off-target activity of RAG itself at cryptic RSSs could all create 
DSBs with the potential to translocate with cleaved antigen receptor loci. Translocations 
of antigen receptor loci pose a particular oncogenic risk as they contain enhancers and 
promoters that are highly active in developing lymphocytes, which if translocated could 
drive the expression of a proto-oncogene. Indeed, many lymphoid cancers in humans 
and in mouse models involve clonal AgR translocations that are believed to promote 
oncogenesis (Leder et al., 1983; Schlissel, 2006). In this context, it is plausible that a 
developing lymphocyte might avoid creating a DSB at an antigen receptor locus when a 
DSB already exists at another location in the genome.  
 Indeed, we find that DSBs suppress RAG expression and V(D)J recombination; 
this central finding is discussed in Chapter 2. Chapter 3 focuses on the signaling events 
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necessary for this suppression. Chapters 2 and 3 focus on how exogenous sources of 
DNA damage suppress RAG expression and V(D)J recombination. However, V(D)J 
recombination itself requires DNA damage, and in this context suppression of RAG 
expression can be considered a negative feedback loop. Chapter 4 discusses how 
defects in this feedback loop can increase allelic inclusion in lymphocytes. Collectively, 
these results suggest that developing lymphocytes employ a conserved pathway to react 
to a programmed developmental stimulus (RAG-mediated DSBs) and non-programmed 
stimulus (exogenous DSBs). While the regulation of RAG expression by developmental 
cues has been well studied, this work shows that RAG expression can also be regulated 
by external factors.  
26 
 
Figure 1.1 
 
Figure 1.1: Schematic of V(D)J recombination. (A) Germline antigen receptor antigen 
receptor locus. Rag cleaves recombination signal sequences adjacent to D and J 
segments, creating a DJ join. (B) In a second round of RAG activity, a V segment 
rearranges to the DJ segment to create (C) a complete VDJ rearrangement.  
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Figure 1.2 
 
Figure 1.2: Overview of lymphocyte development. B and T lineages diverge from a 
common progenitor and undergo recombination of specific antigen receptor loci at 
defined developmental stages. Background shading represents high Rag expression 
(dark areas) or low Rag expression (light areas) at each developmental stage. 
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Figure 1.3 
 
Figure 1.3: Diagram of Rag1 and Rag2 genes and associated regulatory elements. The 
grid shows proteins known to bind each element. "B" indicates binding in developing B 
cells, "T" indicates binding in developing T cells, "DN T" indicates binding only in CD4- 
CD8- thymocytes. "CLP" indicates binding in the common lymphoid progenitor. The 
factors that regulate Rag1 and Rag2 transcription are largely distinct between B and T 
cells. Sources: 1 (Fuller and Storb, 1997); 2 (Hsu et al., 2003); 3 (Novak et al., 2010); 4 
(Borghesi et al., 2005); 5 (Reynaud et al., 2008); 6 (Wei et al., 2005); 7 (Amin and Schlissel, 
2008); 8 (Dengler et al., 2008); 9 (Herzog et al., 2008); 10 (Hu et al., 2006); 11 (Lauring and 
Schlissel, 1999); 12 (Kishi et al., 2000); 13 (Miranda et al., 2002); 14 (Lee et al., 2013); 15 
(Schulz et al., 2012); 16 (Verkoczy et al., 2005); 17 (Kishi, 2002); 18 (Fong et al., 2000); 19 
(Wang et al., 2000); 20 (Brown et al., 1997); 21 (Jin et al., 2002); 22 (Okamura et al., 1998); 
23 (Wei et al., 2002); 24 (Yannoutsos et al., 2004) 2004; 25 (Hao et al., 2015); 26 (Reed et 
al., 2013); 27 (Patra et al., 2006). Adapted and updated from (Kuo and Schlissel, 2009)
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Chapter 2: DSBs suppress Rag1 and Rag2 expression and V(D)J 
recombination1 
Abstract 
 Developing lymphocytes must rearrange the genomic sequence of appropriate 
antigen receptor genes by V(D)J recombination. The lymphocyte-specific endonuclease 
RAG, composed of Rag1 and Rag2, initiates this process by cleaving specific sites within 
antigen receptor loci. RAG expression is regulated to ensure that V(D)J recombination 
occurs only under appropriate circumstances. The Bassing laboratory previously 
demonstrated that RAG-mediated DNA cleavage in pre-B cells initiates a feedback-
inhibition signal suppressing RAG expression. Here, we show that non-RAG mediated 
DNA double strand breaks (DSBs) have a similar effect in suppressing mRNA expression 
of Rag1 and Rag2. This effect can be observed in pro-B cells, pre-B cells, and DN 
thymocytes, but not in DP thymocytes. In pre-B cells, loss of Rag1 and Rag2 mRNA 
expression leads to loss of Rag1 protein, but Rag2 protein level is unaffected due to high 
protein stability. Suppression of Rag1 expression by DSBs is associated with suppressed 
RAG-mediated cleavage of the Igκ locus or an artificial recombination substrate in 
                                                      
1 Parts of this chapter were published in The Journal of Immunology. Copyright © 2017 The American 
Association of Immunologists, Inc. Fisher MR, Rivera-Reyes A, Bloch NB, Schatz DG, Bassing CH. Immature 
Lymphocytes Inhibit Rag1 and Rag2 Transcription and V(D)J Recombination in Response to DNA Double-
Strand Breaks. J. Immunol. [Epub ahead of print 2017 Feb 17]. Portions of this chapter were prepared 
jointly with Noah Bloch. 
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Abelson-transformed pre-B cells. However, simply over-expressing Rag1 does not allow 
cells to complete V(D)J recombination in the presence of DSBs, suggesting that other 
factors may also play a role in suppressing V(D)J recombination.  
Introduction 
 Adaptive immunity requires the production of lymphocytes capable of 
recognizing a broad and often unpredictable array of potential foreign antigens. In 
jawed vertebrates, B and T lymphocytes achieve the necessary diversity of antigen 
receptors by V(D)J recombination (Tonegawa, 1983). In this process, the Rag1/Rag2 
endonuclease (RAG) makes paired DNA double strand breaks (DSBs) at recombination 
signal sequences (RSSs) adjacent to variable (V), diversity (D), or joining (J) gene 
segments within a selected antigen receptor locus; intervening DNA is either deleted or 
inverted, and the DSBs are repaired by ubiquitous Non-Homologous End Joining (NHEJ) 
factors (Helmink and Sleckman, 2012). The combination of V, D, and J segments, the 
semi-random addition and removal of a limited number of nucleotides at the 
breakpoints, and the use of two independently rearranged antigen receptor chains in 
each receptor all contribute to the receptor diversity generated by V(D)J recombination 
(Tonegawa, 1983). 
 V(D)J recombination is absolutely required for B and T cell development, as 
failure to rearrange a complete antigen receptor leads to death of progenitor 
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lymphocytes (Miosge and Goodnow, 2005). At each stage, the expression of the V(D)J 
catalyst (RAG) and the accessibility of the substrate (antigen receptor genes) are both 
regulated to ensure that the appropriate genes are rearranged at the appropriate time 
(Vettermann and Schlissel, 2010). Antigen receptor genes are prepared for 
rearrangement in the appropriate developmental stage by a process of histone 
modification, precise nucleosome positioning, and DNA-looping to bring distant gene 
segments into close proximity (Stanhope-Baker et al., 1996; Mandal et al., 2015; Hu et 
al., 2015). Furthermore, expression of the RAG endonuclease is restricted to certain 
stages of B and T cell development. Developing B cells first rearrange the 
immunoglobulin heavy chain (IgH) chain locus as pro-B cells, and expression of a 
functional IgH allele suppresses RAG expression and promotes progression to the pre-B 
cell stage (Übelhart et al., 2015). After a series of cell divisions at the large pre-B1 stage, 
re-expression of RAG in small resting pre-B2 cells allows light chain rearrangement and 
expression of a complete B cell receptor (BCR) . Developing αβT cells go through a 
similar process in which rearrangement of the TCRβ gene in DN thymocytes leads to 
progression to the DP thymocyte stage and rearrangement of the TCRα gene (Miosge 
and Goodnow, 2005).  
Different transcription factors and genetic regulatory elements drive Rag1 and 
Rag2 expression in developing B and T cells. For example, the Erag enhancer promotes 
Rag1 and Rag2 transcription in both pro- and pre-B cells, but does not seem to affect 
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expression in developing T cells (Hsu et al., 2003). Conversely, interplay between a 
silencer and anti-silencer element control Rag1 and Rag2 expression in DP thymocytes 
cells, but this system is only partially responsible for Rag1 and Rag2 transcription in DN 
thymocytes, and not at all necessary in developing B cells (Yannoutsos et al., 2004). 
However in both developing B and T cells, key developmental events either promote or 
suppress RAG expression; for example, cell surface expression of a functional, non-
autoreactive antigen receptor chain suppresses RAG expression in both developing B 
and T cells (Turka et al., 1991; Li et al., 1993; Verkoczy et al., 2007). Such regulation 
ensures that V(D)J recombination does not happen at inappropriate developmental 
stages.  
 Although crucial for lymphocyte development, the deliberate formation of DSBs 
during V(D)J recombination creates a risk of translocation if the process goes awry. 
Richardson et al. show that co-existence of two DSBs at two different loci increases the 
risk of translocation between those loci by several orders of magnitude (Richardson and 
Jasin, 2000); therefore RAG-mediated DNA cleavage of an antigen receptor gene pose a 
risk of translocation if another DSB already exists in the cell. Normal cellular 
metabolism, genotoxic environmental factors, or off-target activity of RAG itself at sites 
that mimic RSSs (cryptic RSSs) could all create DSBs with the potential to translocate 
with antigen receptor loci cleaved by RAG (Schlissel, 2006). Translocations of antigen 
receptor loci pose a particular oncogenic risk as their enhancers and promoters are 
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highly active in developing lymphocytes and could drive the expression of a proto-
oncogene if translocated. Indeed, many lymphoid cancers in humans and in mouse 
models involve clonal antigen receptor translocations that are believed to promote 
oncogenesis (Küppers and Dalla-Favera, 2001). 
 To combat the risks of DNA-double strand breaks, eukaryotic cells including 
lymphocytes employ conserved DNA damage response (DDR) mechanisms. DSBs 
activate the Ataxia Telangiectasia mutated (ATM) protein, which serves as the key 
regulator of cellular responses to DSBs by phosphorylating a variety of substrates 
leading to cell cycle arrest and DSB repair (Shiloh and Ziv, 2013). Lack of ATM function 
allows genomic instability, and both humans and mice deficient for ATM are susceptible 
to leukemias and lymphomas (Barlow et al., 1996; Taylor et al., 1996). Several studies 
have demonstrated that RAG-induced DSBs in developing lymphocytes activate ATM 
and downstream DDR pathways (Bredemeyer et al., 2008). In this context, ATM 
promotes efficient repair of RAG-induced DSBs (Bredemeyer et al., 2006; Huang et al., 
2007). Previous work in the Bassing laboratory has demonstrated that ATM activation by 
RAG-mediated DSBs can also suppress the induction of RAG-mediated DSBs in pre-B 
cells. Specifically, RAG-induced DSB on one Igκ allele in pre-B cells suppresses RAG 
mRNA and protein expression and prevents cleavage of the second Igκ allele in an ATM-
dependent manner (Steinel et al., 2013). 
34 
 
As discussed above, the co-existence of multiple DSBs in a cell seriously increases 
the risk of translocation. Given the need to prevent antigen receptor translocations 
during V(D)J recombination, we hypothesized that exogenously-induced DSBs would 
suppress RAG expression and function, just as RAG-mediated DSBs do. We find that 
etoposide-induced DSBs suppress RAG expression and V(D)J recombination in pre-B cell 
lines. Exposure to ionizing radiation (IR) to induce DSBs suppresses Rag1 and Rag2 
mRNA expression in pro- and pre-B cells and in DN thymocytes, but not in DP 
thymocytes. We discuss the possibility that suppression of RAG expression and activity 
protects genomic stability of developing lymphocytes by preventing RAG-mediated 
antigen receptor locus cleavage in the presence of another DSB that could promote 
translocation. 
Results 
DSBs in pre-B cells suppress Rag1 and Rag2 mRNA expression 
 The Bassing laboratory has previously shown that RAG-mediated DSBs in pre-B 
cells activate the DNA-damage response protein ATM to suppress Rag1 and Rag2 mRNA 
expression and inhibit further RAG activity (Steinel et al., 2013). We hypothesized that 
exogenously-induced DNA damage would share this suppressive effect on RAG 
expression and V(D)J recombination in pre-B cells. To test this we used the two model 
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systems previously used to demonstrate the suppressive effect of RAG-mediated breaks: 
IL-7 withdrawn ex vivo pre-B cells, and Abelson-transformed pre-B cell lines.  
 EμBCL2 primary pre-B cells can be grown for several days ex vivo with IL-7 to 
expand the pre-B cell pool, and then withdrawn from IL-7 to induce RAG expression and 
V(D)J recombination (Ray et al., 1998). This Bcl2 transgene is expressed in B and T 
lineage cells and allows these cells to survive in culture and protects cells from apoptosis 
upon exposure to DNA damage (Strasser et al., 1991a, 1991b). To determine the effect 
of non-RAG mediated DSBs on pre-B cells, we exposed these cells to 4 Gy ionizing 
radiation (IR). As a control to show that the cells experienced a DNA damage response, 
we measured the induction of p21 mRNA caused by IR; we found that exposure to IR or 
other DNA damaging agents caused the expected increase in p21 mRNA expression in all 
cases (Fig. 2.1a,c,d). From one hour through four hours after IR exposure, Rag1 and 
Rag2 mRNA expression in ex vivo pre-B cells decreased by approximately 80%. By 8 
hours after IR exposure, Rag1 and Rag2 expression in these cells recovered to normal 
levels (Fig. 2.1a). To rule out any role for RAG-induced DNA breaks in this response, we 
turned to Abelson-transformed pre-B cell lines pre-treated with sti571 to induce Rag1 
and Rag2 expression (Muljo and Schlissel, 2003). We compared the effect of IR on wild-
type Abelson cells and Abelson cells expressing a cleavage-incompetent Rag1 mutant 
protein (Rag1D708A). We found that both wild-type and Rag1D708A cells suppressed Rag1 
and Rag2 mRNA expression in response to IR, although the response was slower than in 
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primary cells (Fig. 2.1b). These results show that IR can suppress Rag1 and Rag2 
expression without any contribution from RAG-mediated DSBs. 
 These results suggest that exogenously induced DSBs can suppress Rag1 and 
Rag2 expression. However, IR causes many kinds of cellular damage in addition to DSBs. 
To more specifically test the effect of DSBs, we tested the effect of two genotoxic drugs 
on Rag1 and Rag2 expression in IL-7 withdrawn pre-B cells. The drug etoposide poisons 
type II topoisomerase and prevents them from religating the DNA strands (Montecucco 
et al., 2015). Bleomycin induces DSBs, but may also damage RNA (Hecht, 2000). 
Exposure to 10μg/mL etoposide leads to a rapid decrease in Rag1 and Rag2 mRNA 
expression by approximately 90% (Fig. 2.1c). Similarly, exposure to 5μM bleomycin leads 
to an approximately 75% decrease in Rag1 and Rag2 mRNA expression (Fig. 2.1d). 
Collectively, these results show that the DSB response in pre-B cells involves turning off 
Rag1 and Rag2 expression.  
DSBs suppress Rag1 and Rag2 expression in bone marrow and thymus. 
 Rag1 and Rag2 are expressed at defined stages of B and T cell development, and 
different transcription factors and genetic elements regulate its expression in different 
cell types (Hsu et al., 2003; Yannoutsos et al., 2004). Because of this heterogeneity, we 
decided to test whether the effect of DNA damage was specific to pre-B cells, or shared 
by other RAG-expressing lymphocytes. To survey the effect of DSBs on a variety of 
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developing lymphocyte populations, we exposed live EμBCL2 mice to 10Gy IR. The Bcl-2 
transgene is expressed in both B and T lineage cells in these mice (Strasser et al., 1991a). 
We then isolated bone marrow (BM) or thymocytes from irradiated mice 1 or 4 hours 
after IR, and from unirradiated control mice to measure Rag1 and Rag2 mRNA levels by 
qPCR. As a control to show that the cells experienced a DNA damage response, we 
measured the induction of p21 mRNA caused by IR. Upon IR, we found that Rag1 
expression in EμBCL2 BM decreases by approximately 75%, while Rag2 expression 
decreases by approximately 60%. (Fig. 2.2a). To demonstrate that this response is not 
somehow caused by the EμBCL2 transgene we performed a similar experiment using 
wild-type mice. BM from wild-type mice suppressed Rag1 and Rag2 expression by 
approximately 90% in response to IR (Fig. 2.2c). In contrast, IR exposure does not 
suppress Rag1 or Rag2 mRNA expression in EμBCL2 thymocytes, and may even lead to 
increased expression (Fig. 2.2b). We found a similar effect using wild-type thymocytes 
(Fig. 2.2d). In bone marrow of wild-type or EμBCL2 mice, most RAG-expressing are pre-B 
or immature B cells, relatively late developmental stages. Similarly, Rag-expressing cells 
in the thymus consist largely of DP thymocytes, the T cell developmental stage 
analogous to the pre-B cell stage. Therefore, these results likely reflect the response of 
pre-B cells and pre-T cells to DSBs, while the effect on pro-B cells ad pro-T cells is 
masked by their relatively low numbers. 
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DSBs suppress Rag1 and Rag2 expression in early stages of B and T cell development 
 To determine the effect of IR on Rag1 and Rag2 mRNA expression at earlier 
stages of B and T cell development, we repeated the experiments above using Rag2-/- 
and Rag1-/- mice. In these mice, B cell development is arrested at the pro-B cell stage, 
and T cell development is arrested at the DN thymocyte stage (Hao and Rajewsky, 2001; 
Mombaerts et al., 1992a). Therefore, in a Rag-deficient mouse, the Rag-expressing cells 
in the BM consist largely of pro-B cells and earlier precursors, while Rag-expressing cells 
in the thymus consist of DN thymocytes. Again, increased p21 expression indicated that 
these tissues experienced DNA damage (Fig 2.3a-d). Rag1 expression in both the BM of 
Rag2-/- mice decreases approximately 80% upon exposure to 10Gy IR (Fig. 2.3a); 
similarly, Rag2 expression in BM of Rag1-/- mice decreases upon exposure to IR (Fig. 
2.3b). Interestingly, IR caused an approximately 50% decrease in Rag1 expression in 
Rag2-/- thymocytes (Fig. 2.3c), and a similar decrease in Rag2 expression in Rag1-/- 
thymocytes (Fig2.3d). Although less robust than the effect in BM, this suppression is 
strikingly different from the modest induction of Rag1 and Rag2 upon exposure of wild-
type thymocytes to IR. Therefore, we conclude that DSBs can suppress Rag1 and Rag2 
expression at early stages of both B and T cell development; this ability persists in B cells 
through the pre-B cell stage, but is lost in T cells as they develop to the DP stage. These 
findings are consistent with the fact that regulation of basal Rag1 and Rag2 mRNA 
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expression in developing B and T cells is relies on different genetic elements and 
transcription factors, as discussed in Chapter 1. 
DSBs suppress Rag1 but not Rag2 protein levels 
 The previously reported half-lives of both Rag1 and Rag2 half-life are very short, 
from 10-30 minutes (Grawunder et al., 1996; Lin and Desiderio, 1993; Ochodnicka-
Mackovicova et al., 2015). Therefore, we expected the expression of both proteins to 
decrease rapidly as their mRNA expression was suppressed after IR. However, when we 
measured protein expression in irradiated IL-7 withdrawn pre-B cells, we unexpectedly 
found that only Rag1 protein levels decreased within the timecourse of these 
experiments; Rag2 protein levels remained consistent for several hours after induction 
of DNA damage by etoposide or IR (Fig. 2.4a&b). The persistence of Rag2 protein 
expression in the absence of its mRNA suggests that the protein is more stable than 
previously reported (Lin and Desiderio, 1993). This seemed particularly plausible as the 
half-life of wild-type Rag2 has only been reported using asynchronously dividing cell 
lines, and Rag2 is known to be degraded at the G1/S checkpoint (Li et al., 1996).  
The half-life of Rag2 is immeasurably long 
 To measure the half-life of Rag2 protein in G1-arrested cells capable of carrying 
out V(D)J recombination, we treated IL-7 withdrawn pre-B cells with the ribosome 
inhibitor cycloheximide (CHX) and quantified Rag2 levels after treatment. We could not 
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detect a decrease in Rag2 levels earlier than 24 hours after CHX addition, at which point 
the cells began to die from the treatment (Fig. 2.4c&d). We also measured expression of 
the short-lived c-myc protein to confirm that the CHX treatment effectively stopped new 
protein translation. c-myc protein was rapidly depleted by CHX treatment (Fig. 2.4c&d). 
These results show that the Rag2 protein is remarkably stable, explaining the persistent 
Rag2 protein expression in the absence of Rag2 mRNA. In contrast, Rag1 protein levels 
decrease similarly to Rag1 mRNA levels. This may be because Rag1 protein is 
intrinsically less stable than Rag2. Alternatively, IR may induce degradation of existing 
Rag1 protein in addition to preventing new protein synthesis by suppressing Rag1 
mRNA expression. In either case, transcriptional suppression of both Rag1 and Rag2 has 
a rapid effect on the abundance only of Rag1 protein. While both Rag1 and Rag2 are 
absolutely required for RAG cleavage activity, Rag1 is normally present at much lower 
levels than Rag2 in developing lymphocytes (Zhang et al., 2015). Therefore, modulating 
Rag1 expression might be a more sensitive way to regulate cleavage activity than Rag2 
expression. 
DSBs inhibit RAG-mediated cleavage of the Igκ allele. 
 To determine whether suppression of Rag1 and Rag2 mRNA expression was 
associated with inability to initiate V(D)J recombination, we treated an Artemis-deficient 
Abelson pre-B cell line with the DSB-inducing agent etoposide. Upon addition of the v-
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abl inhibitor sti571, these cells arrest in the G1 cell cycle stage, induce Rag expression, 
and cleave the Igκ locus (Muljo and Schlissel, 2003). Artemis-deficient cells cannot repair 
RAG-mediated DSBs, so the accumulation of these breaks can be measured by Southern 
blotting. Etoposide was added to the cells after 24-hours of pretreatment with sti571. 
Consistent with the results of short-term DSB exposure in primary cells, exposure to 
etoposide in these experiments suppressed Rag1 and Rag2 mRNA expression and 
induced p21 mRNA expression (Fig. 2.5a). Furthermore, addition of etoposide halted the 
accumulation of cleaved Igκ loci, while untreated cells continued to accumulate cleaved 
loci over the following 24 hours (Fig 2.5b). We found the same suppressive effect on Rag 
expression and Igκ cleavage by treating the cells with bleomycin instead of etoposide 
(Fig. 2.5c&d).  
 Unfortunately, Rag1 and Rag2 protein expression in these cells is too low to 
measure reliably by western blot. Therefore we could not definitively determine 
whether Rag1 and Rag2 protein expression in Abelson cells exposed to etoposide or 
bleomycin for long time periods follows the same pattern found in primary pre-B cells 
exposed to IR, in which Rag1 protein decreases while Rag2 is maintained. 
 We repeated this experiment using an Artemis-sufficient Abelson cell line, to rule 
out the possibility that abnormal repair of Rag-mediated DSBs in the absence of Artemis 
causes the decrease in RAG activity. In this case, RAG makes breaks at Igκ loci which are 
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rearranged in a variety of configurations, leading to loss of the germline Igκ band. Using 
wild-type Abelson cells, we found that addition of etoposide prevents disappearance of 
the germline Igκ band, indicating that V(D)J recombination is halted (Fig. 2.5f). As in the 
Artemis-deficient lines, exposure to etoposide suppressed Rag1 and Rag2 mRNA 
expression and induced p21 expression throughout the course of the experiment (Fig. 
2.5e). These results show that exposure to DSBs prevents the RAG-mediated initiation of 
V(D)J recombination in pre-B cells. 
Suppression of V(D)J recombination is not specific to the Igκ locus. 
 In principle, V(D)J recombination can be regulated globally, for example by 
manipulating factors like RAG necessary for recombination, or locally, for example 
regulating accessibility of a specific antigen receptor locus to RAG. To determine 
whether the inability of etoposide-treated pre-B cells to undergo V(D)J recombination 
extends beyond the Igκ locus, we measured recombination of an artificial recombination 
substrate (pMX-INV) in an etoposide-treated Abelson line (Gapud et al., 2011). This 
substrate is chromosomally integrated, and therefore could be subject to broadly-acting 
alterations in chromosome that could affect RAG activity. However, we do not expect it 
to be specifically targeted in the way the Igκ locus could be. This substrate contains an 
anti-sense GFP gene flanked by RSSs. RAG activity on this substrate inverts the GFP 
gene, turning on GFP expression (Fig. 2.6a). We first treated these cells with sti-571 for 
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24 hours. Within this time, Rag1 and Rag2 mRNA expression turned on, and 
approximately 10% of the cells expressed GFP, indicating they had rearranged the 
substrate (Fig. 2.6b&c). After 24 hours of sti-571 treatment, the culture was divided and 
treated with either 10μg/mL etoposide or vehicle control. The control cell continued to 
upregulate Rag1 mRNA expression, and the proportion of GFP+ cells increased to 40%. 
In contrast, Rag1 and Rag2 expression decreased dramatically in etoposide-treated 
cells, and the proportion of GFP+ cells remained at 10%, as it was at the time of 
etoposide addition (Fig. 2.6b&c). We conclude that DSBs suppress V(D)J recombination 
in general, and this effect does not require factors specific to the Igκ locus. 
Enforced Rag1 expression does not restore the ability to complete V(D)J 
recombination in the presence of DNA damage 
 Next, we tested the ability of Rag1-overexpression to overcome inhibition of 
V(D)J recombination by DSBs. We tested the effects of Rag1 alone, because the 
experiments shown in Fig. 2.4 show that Rag2 protein has a long halflife, so we do not 
expect that its expression is affected by DSBs. We transfected pMX-INV+ cells with 
retrovirus containing Rag1 cDNA or an empty vector. We then treated these cells as 
described above, first with sti-571 for 24 hours, then adding etoposide or vehicle control 
for an additional 48 hours. Empty-vector transduced cells behaved similarly to the 
untransduced cells, in that etoposide treatment inhibited both Rag1 and Rag2 
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expression and recombination of the artificial substrate (Fig. 2.6d&e). As expected, the 
Rag1-transduced cells express far higher levels of Rag1 mRNA than vector-transduced 
cells at all timepoints (Fig. 2.6d). Like in vector-transduced cells, Rag2 mRNA expression 
is high in vehicle-treated cells and low in etoposide treated cells (Fig. 2.6d). Rag1 
overexpression does not allow these cells to undergo pmx-INV recombination in the 
presence of etoposide; among cells exposed to vehicle control the GFP+ cells increase 
from 10% to 45% over 48 hours, while cells exposed to etoposide halt rearrangement 
and remain approximately 10% GFP+ (Fig. 2.6e). We conclude that simply maintaining 
Rag1 mRNA expression at a high level in the presence of etoposide does not prevent 
inhibition of V(D)J recombination by DSBs. 
Discussion 
 These studies show that DSBs caused by a variety of factors can suppress Rag1 
and Rag2 mRNA expression in pre-B cells, leading to a loss of Rag1 protein. In vivo 
studies suggest that this response is shared by pro- and pre-B cells, and to a lesser 
extent DN thymocytes. However, we found no evidence that DSBs inhibit Rag1 or Rag2 
expression in DP thymocytes. We found that exposure to DSBs prevented cleavage of 
the Igκ locus and rearrangement of an artificial recombination substrate in pre-B cell 
lines. However, this inhibition was not relieved by constitutive expression of Rag1 
mRNA, suggesting that additional factors may play a role in inhibiting V(D)J 
recombination in response to DSBs. 
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 The loss of Rag1 and Rag2 mRNA leads to selective loss of Rag1 protein, while 
the relatively stable Rag2 protein persists in the absence of its mRNA. Both Rag1 and 
Rag2 are absolutely required for RAG-mediated cleavage. At basal levels, Rag1 protein is 
far less abundant than Rag2 protein (Zhang et al., 2015). Therefore Rag1 availability 
might be a limiting factor and a more responsive target for regulating V(D)J 
recombination activity. 
 The failure of constitutive Rag1 mRNA expression to restore V(D)J recombination 
activity in the presence of etoposide suggests that additional signals beyond 
suppression of Rag1 expression are involved. Possibilities include post-translational 
modifications that inactivate any Rag1 protein that persists, or inactivating 
modifications of Rag2 protein. Both Rag1 and Rag2 contain S/TQ motifs, the target 
sequence for the ATM kinase and related PI3K-like kinases including DNA-PKcs (Gapud 
et al., 2011). Indeed, DNA-PKcs can phosphorylate Rag2 in vitro (Hah et al., 2007). 
Phosphorylation by other factors might also play a role. For example, the metabolic 
sensor AMPK was shown to increase Rag1 cleavage activity by phosphorylating Rag1 on 
amino acid S528 (Um et al., 2013); this might be prevented by DSB. Other post 
translational modifications might also be affected, such as the autoubiquitylation of 
Rag1 that normally increases its cleavage ability (Singh and Gellert, 2015). 
46 
 
 In fact there is already evidence that Rag2 is phosphorylated in the presence of 
DSBs. Rodgers et al. have shown that a portion of the Rag2 protein pool is exported 
from the nucleus following IR of Abelson-transformed pre-B cells (Rodgers et al., 2015). 
The purpose of this export is unclear, particularly as over half of total Rag2 protein 
remains nuclear. However, export was shown to require the cdk-phosphorylation site 
T490, suggesting that at least some fraction of available Rag2 is phosphorylated at this 
site following IR. Phosphorylation at T490 of Rag2 is normally associated with 
degradation (Lin and Desiderio, 1993); however the persistent Rag2 expression 
observed in our study and in the Rodgers study suggests that this is not the case in the 
context of DSBs. Skp2-SCF, the E3 ligase implicated in Rag2 ubiquitylation after T490 
phosphorylation, is poorly expressed in G1 phase until just before the G1/S transition 
(Jiang et al., 2005; Bilodeau et al., 1999); therefore, T490 phosphorylation of Rag2 in G1-
arrested cells, like those used in our study, may lead to fates other than degradation. 
Alternatively, Rag2 protein might be inactivated by post-translational modifications that 
leave its expression intact. 
 Another potential method of suppressing RAG activity is to decrease the 
accessibility of target antigen receptor loci. It was recently found that RAG-mediated 
DSBs induce expression of the Ets-family member Spi-c, which competes with 
transcriptionally active Ets family members for binding at the Igκ locus and decreases 
Igκ accessibility and RAG-mediated cleavage (Bednarski et al., 2016). We also find 
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induction of Spi-c mRNA expression in our recombination assays, although etoposide 
treatment causes only a slight increase in Spi-c expression above the level induced by 
RAG-mediated DSBs alone (discussed further in Chapter 4). However, the ability of 
etoposide treatment to inhibit recombination of an artificial recombination substrate 
suggests that locus-specific factors such as Spi-c are not required to inhibit 
recombination, even if they do contribute to regulation of endogenous loci. 
 It is also possible that DSBs normally suppress V(D)J recombination by 
suppressing Rag1 expression, but that details of our experimental setup account for the 
failure of constitutive Rag1 mRNA expression to rescue. For example, the 48 hour DSB 
exposure used in our experiments is far longer than the time normally required to repair 
DSBs (Rothkamm et al., 2003). This long DSB exposure might have effects that would not 
be relevant to a developing lymphocyte experiencing only normal levels of DSB 
exposure. For example, Rag2 protein expression might decrease during this long time 
course. We assume that Rag2 protein half-life is long in Abelson cells, as it is in primary 
pre-B cells. However, we cannot directly measure this because basal expression of Rag2 
in Abelson cells is much lower than in primary cells and cannot be reliably detected by 
western blotting. Indeed, the fact that both Rag1 and Rag2 proteins have low expression 
in Abelson cells but mRNA expression is comparable with primary cells suggests that 1) 
translation of these mRNAs is lower in Abelson cells, or 2) the half-life of the proteins is 
shorter. Therefore, it is possible that in the systems we used to measure V(D)J 
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recombination, both Rag1 and Rag2 protein expression decreases in the presence of 
DSBs, and that constitutive expression of both proteins would allow V(D)J 
recombination activity in the presence of DSBs. 
 The differential regulation of Rag1 and Rag2 mRNA expression observed in 
different lymphocyte subsets is not entirely surprising, as it has long been known that 
different transcription factors and different enhancer elements drive basal Rag1 and 
Rag2 expression in different kinds of lymphocytes. The Erag, Ep, and Ed enhancers are 
all active in pro- and pre-B cells (Hsu et al., 2003; Wei et al., 2002, 2005). Erag is also 
active in the common lymphoid progenitor (Borghesi et al., 2005). The Ed enhancer is 
also active in DN thymocytes, but none of these three elements affect Rag1 or Rag2 
expression in DP thymocytes. Instead, the ASE overcomes a highly active silencer 
element to allow Rag1 and Rag2 expression in DP thymocytes; the ASE has some activity 
in DN thymocytes, but none in pro- or pre-B cells (Yannoutsos et al., 2004). The pattern 
of required enhancers is reminiscent of the pattern of Rag1 and Rag2 suppression by 
DSBs: a strong effect in pro- and pre-B cells, which generally use the same regulatory 
elements for Rag1 and Rag2; modest suppression in DN thymocytes, which uses one 
enhancer element in common with developing B cells; and no suppression in DP 
thymocytes, which uses an entirely different enhancer to regulate Rag1 and Rag2 
transcription. While not conclusive, this pattern suggests that 1) DSBs suppress Rag1 
and Rag2 mRNA expression by inhibiting their transcription, and 2) this regulation 
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involves regulatory elements used by pro- and pre-B cells as well as DN thymocytes. The 
Ed enhancer is the only identified element that fits this description; additional 
involvement of the B cell-specific Erag and Ep enhancers might explain the more 
effective suppression in pro- and pre-B cells. Additional experiments will be necessary to 
determine whether these elements are the main targets of DSB signaling that lead to 
the suppression of Rag1 and Rag2 expression. 
 Identification of critical genetic elements regulating Rag1 and Rag2 expression in 
response to DSBs could allow us to mutate these elements and selectively abrogate this 
response in in vivo developing lymphocytes. This would allow us to explore the role of 
this response in lymphocyte development. As discussed in the introduction to this 
chapter, we suggest that this signal plays a role in maintaining genomic stability by 
preventing the creation of RAG-mediated DSBs at an antigen receptor locus while 
another DSB exists that might lead to a translocation. Future experiments will attempt 
to address this hypothesis by preventing the normal suppression of Rag1 and Rag2 
expression during lymphocyte development in vivo, and measuring the frequency of 
antigen receptor translocations and/or development of lymphoid malignancies. We also 
have reason to believe that RAG-mediated DSBs activate the same signal to help prevent 
simultaneous rearrangement of two antigen receptor alleles, enforcing allelic exclusion. 
This effect will be discussed in Chapter 4. 
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Figure 2.1 
 
Figure 2.1: DSBs induced by a variety of agents suppress Rag1 and Rag2 mRNA 
expression in pre-B cells. (A) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in 
non-irradiated and irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 
Gy IR. Data are from 11 independent experiments. (B) qRT-PCR quantification of Rag1 
and Rag2 mRNA expression in a wild-type Abelson cell line and a Rag1-mutant cell line 
at indicted times after exposure to 4 Gy IR. Data are from 3 independent experiments. 
(C) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in EμBCL2 pre-B cells at 
indicated times after addition of 10 μg/mL etoposide to culture media. Data are from 3 
independent experiments. (D) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in 
EμBCL2 pre-B cells at indicated times after addition of 5 μM bleomycin to culture media. 
Data are from 3 independent experiments. (A-D) Data are normalized to 1.0 for 
untreated cells within each experiment. For treated cells, data averages are shown with 
error bars indicating SEM. p-values calculated using Dunnett's post-test after ANOVA.  
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Figure 2.2 
 
Figure 2.2: DSBs suppress Rag1 and Rag2 mRNA expression in BM but not thymus. (A) 
qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in BM from non-irradiated EμBCL2 
mice or EμBCL2 mice at indicated times after exposure to 10 Gy IR. Data are from one 
experiment with 3-4 mice for each timepoint. (B) qRT-PCR quantification of Rag1, Rag2, 
and p21 mRNA in thymuses from non-irradiated EμBCL2 mice or EμBCL2 mice at 
indicated times after exposure to 10 Gy IR. Data are from three independent 
experiments including a total of 4-6 mice per timepoint. (C) qRT-PCR quantification of 
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Rag1, Rag2, and p21 mRNA in BM from non-irradiated wild-type mice at indicated times 
after exposure to 10 Gy IR. Data are from two independent experiments including a 
total of 4-5 mice per timepoint. (D) qRT-PCR quantification of Rag1, Rag2, and p21 
mRNA in thymus from non-irradiated wild-type mice or wild-type mice at indicated 
times after exposure to 10 Gy IR. Data are from two independent experiments including 
a total of 4-5 mice per timepoint. (A-D) Data averages are shown with error bars 
indicating SEM. p-values calculated using Dunnett's post-test after ANOVA.  
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Figure 2.3 
 
Figure 2.3: DSBs suppress Rag1 and Rag2 mRNA expression in both pro-B cells and pro-T 
cells. (A) qRT-PCR quantification of Rag1 and p21 mRNA in BM from non-irradiated 
Rag2-/- mice or Rag2-/- mice at indicated times after exposure to 10 Gy IR. Data are from 
one experiment with 3 or 4 mice per timepoint. (B) qRT-PCR quantification of Rag2 and 
p21 mRNA in BM from non-irradiated Rag1-/- mice or Rag1-/- mice at indicated times 
after exposure to 10 Gy IR. Data are from three independent experiments with 4-6 mice 
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per timepoint. (C) qRT-PCR quantification of Rag1 and p21 mRNA in thymus from non-
irradiated Rag2-/- mice or Rag2-/- mice at indicated times after exposure to 10 Gy IR. 
Data are from one experiment with 3 or 4 mice per timepoint. (D) qRT-PCR 
quantification of Rag2 and p21 mRNA in thymus from non-irradiated Rag1-/- mice or 
Rag1-/- mice at indicated times after exposure to 10 Gy IR. Data are from three 
independent experiments with 4-6 mice per timepoint. (A-D) Data averages are shown 
with error bars indicating SEM. p-values calculated using Dunnett's post-test after 
ANOVA.  
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Figure 2.4 
 
Figure 2.4: Rag1 protein expression decreases after IR, but Rag2 protein is maintained. 
(A) Representative western blot analysis depicting Rag1 and Rag2 protein in non-
irradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy IR. 
(B) Quantification of (A). Data are from 8 independent experiments. (C) Representative 
western blot analysis depicting expression of Rag2 and c-Myc protein in cycloheximide-
treated EμBCL2 pre-B cells. (D) Quantification of (C). Data are from 3 independent 
experiments. (A-D) Data are normalized to 1.0 for untreated cells within each 
experiment. For treated cells, data averages are shown with error bars indicating SEM. 
p-values calculated using Dunnett's post-test after ANOVA. 
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Figure 2.5 
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Figure 2.5: DSBs inhibit V(D)J recombination in pre-B cells. (A) qRT-PCR quantification of 
Rag1, Rag2, and p21 mRNA in Artemis-/- EμBCL2 Abl cells untreated or treated with 
STI571 or STI571 and etoposide for the indicated amounts of time. Data are from 6 
independent experiments. (B) Representative Southern blot analysis and graphical 
quantification of Jκ cleavage in Artemis-/- EμBCL2 Abl cells treated with STI571 or STI571 
and etoposide for the indicated amounts of time. Data are from 6 independent 
experiments. (C) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in Artemis-/- 
EμBCL2 Abl cells untreated or treated with STI571 or STI571 and bleomycin for the 
indicated amounts of time. Data are from 3 independent experiments. (D) 
Representative Southern blot analysis and graphical quantification of Jκ cleavage in 
Artemis-/- EμBCL2 Abl cells treated with STI571 or STI571 and bleomycin for the 
indicated amounts of time. Data are from 3 independent experiments. (E) qRT-PCR 
quantification of Rag1, Rag2, and p21 mRNA in EμBCL2 Abl cells untreated or treated 
with STI571 or STI571 and etoposide for the indicated amounts of time. Data are from 3 
independent experiments. (F) Representative Southern analysis and graphical 
quantification of Igκ recombination in EμBCL2 Abl cells untreated or treated with STI571 
or STI571 and etoposide for the indicated amounts of time. Data are from 3 
independent experiments. (A-F) Data averages are shown with error bars the SEM. p-
values were determined by Dunnett's post-test after ANOVA. 
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Figure 2.6 
 
Figure 2.6: DSBs inhibit recombination of an artificial recombination substrate, and 
constitutive Rag1 expression does not overcome inhibition of recombination. (A) 
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Schematic of the pMX-INV recombination substrate before and after RAG-mediated 
recombination. (B) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in EμBCL2-
pINV Abl cells treated with STI571 or STI571 and etoposide for the indicated amounts of 
time. Data are from 3 independent experiments. (C) Quantification of GFP+ cells among 
hCD4+ EμBCL2-pINV Abl cells as determined by flow cytometry. Cells were treated with 
STI571 or STI571 and etoposide for the indicated amounts of time. Data are from 3 
independent experiments. (D) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in 
EμBCL2-pINV Abl cells transduced with empty vector or retrovirus containing Rag1 and 
treated with STI571 or STI571 and etoposide for the indicated amounts of time. Data are 
from 3 independent experiments. (E) Quantification of GFP+ cells among hCD4+ EμBCL2-
pINV Abl cells as determined by flow cytometry. Cells were transduced with empty 
vector or retrovirus containing Rag1 and treated with STI571 or STI571 and etoposide 
for the indicated amounts of time. Data are from 3 independent experiments. (B-E) Data 
averages are shown with error bars the SEM. p-values were determined by Dunnett's 
post-test after ANOVA. 
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Chapter 3: Signaling mechanisms leading to suppression of Rag1 
and Rag2 expression by DSBs1 
Abstract 
 The work presented in Chapter 2 shows that DSBs induced by exogenous factors 
can also suppress Rag1 and Rag2 mRNA expression and V(D)J recombination. Here, we 
discuss the role of specific signaling pathways, particularly ATM and NF-κB, in 
suppressing Rag1 and Rag2 mRNA expression. We find that suppression of Rag1 and 
Rag2 mRNA expression is caused by rapid inhibition of Rag1 and Rag2 transcription. 
This inhibition absolutely requires the activity of the ATM kinase. Inhibition is also 
partially dependent on Nemo and IKKβ activity. Because suppression of Rag1 and Rag2 
expression does not require new protein synthesis, we propose that the 
ATM/Nemo/IKKβ signaling axis leads to post-translational modification of a 
transcriptional regulator present in the cell before DSB exposure. Classically, the 
ATM/Nemo/IKKβ pathway acts by activating NF-κB transcription factors; possible roles 
for NF-κB factors in suppressing Rag1 and Rag2 transcription are discussed. 
                                                      
1 Parts of this chapter were published in The Journal of Immunology. Copyright © 2017 The American 
Association of Immunologists, Inc. Fisher MR, Rivera-Reyes A, Bloch NB, Schatz DG, Bassing CH. Immature 
Lymphocytes Inhibit Rag1 and Rag2 Transcription and V(D)J Recombination in Response to DNA Double-
Strand Breaks. J. Immunol. [Epub ahead of print 2017 Feb 17].  
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Introduction 
 The regulation of basal Rag1 and Rag2 expression is complex; over a dozen 
transcription factors have been implicated in some way in regulating Rag1 and Rag2 
transcription (see Fig. 1.3). Most studies focus on factors that promote Rag1 and Rag2 
transcription in the pro- and pre-lymphocytes expected to complete V(D)J 
recombination, while a few studies examine the ways a functional antigen receptor 
turns off Rag1 and Rag2 expression. One of the clearest findings is that B and T cells use 
largely distinct mechanisms to turn Rag1/Rag2 transcription on and off, employing 
lineage-specific transcription factors that act at different genomic regulatory 
elements(Yu et al., 1999). This is particularly relevant, as we see that developing B cells 
suppress Rag1 and Rag2 expression robustly in response to DSBs, while DN thymocytes 
have a modest response and DP thymocytes do not suppress Rag1 and Rag2 in response 
to DSBs.  
 In developing B cells, the forkhead-box protein Foxo1 is one of the most crucial 
transcription factors promoting Rag1/Rag2 transcription (Amin and Schlissel, 2008; 
Dengler et al., 2008). Several transcription factors necessary for Rag1 and Rag2 
expression also promote Foxo1 expression, suggesting that their effect is at least 
partially indirect; Ikaros and Bcl11a fall into this category (Lee et al., 2013; Reynaud et 
al., 2008). Gfi1b, a negative regulator of Rag1/Rag2 transcription, also works partially by 
suppressing Foxo1 expression (Schulz et al., 2012). Foxo1 binds to the Erag enhancer 
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element, which is critical for Rag1 and Rag2 transcription in developing B cells (Hsu et 
al., 2003; Dengler et al., 2008). Foxo1 activity is terminated by tonic signaling from a 
functional antigen receptor that activates Akt to phosphorylate Foxo1 (Verkoczy et al., 
2007; Amin and Schlissel, 2008; Herzog et al., 2008). 
 Previous work from the Bassing laboratory implicated the DNA damage response 
protein ATM in regulating Rag1 and Rag2 expression. Activation of ATM by DSBs 
normally promotes repair and cell cycle arrest (Shiloh and Ziv, 2013). It was known that 
RAG-mediated DSBs activate ATM, and that ATM activity is important for the efficient 
repair of these breaks and for ensuring developing lymphocytes with cleaved antigen 
receptor loci do not enter cell cycle (Bredemeyer et al., 2006; Callén et al., 2007; Dujka 
et al., 2010).The Bassing laboratory showed that in addition to these functions, RAG-
induced DSBs at the Igκ locus in pre-B cells suppress Rag1 and Rag2 expression. 
Furthermore, ATM prevents pre-B cells from cleaving a second Igκ allele before the first 
is repaired; this signal is believed to be important for normal allelic exclusion of Igκ 
(Steinel et al., 2013).  
 Rag1 and Rag2 are by no means the only targets of ATM activation by RAG-
mediated cleavage of the Igκ locus; in fact, ATM activates hundreds of genes important 
for genomic stability and lymphocyte development (Bredemeyer et al., 2008). Many of 
these targets also require NF-κB activity (Bredemeyer et al., 2008; Bednarski et al., 
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2016). ATM can cooperate in activation of canonical NF-κB signaling by phosphorylating 
the NF-κB essential modifier (Nemo) (Huang et al., 2003). In this context, activated ATM 
and Nemo are exported from the nucleus and promote IKKβ activation and transcription 
of NF-κB target genes (Huang et al., 2000; Verma, 2003). Interestingly, ATM can also 
phosphorylate p65 to suppress transcription of a small subset of p65 target genes, 
opposing the effect of activated Nemo on these genes (Sabatel et al., 2012).  
 DNA damage activates NF-κB signaling in many but not all cell and tissue types. 
Notably, irradiation strongly activates NF-κB activity in bone marrow, but not in 
thymocytes (Zhou et al., 1999). The mechanistic studies discussed in this chapter focus 
on pre-B cells, as these cells can readily be cultured ex vivo. However, we believe that 
similar mechanisms operate in pro-B cells and to some extent in DN thymocytes. In pre-
B cells, we show that DSBs act through the ATM-Nemo signaling pathway to suppress 
Rag1 and Rag2 transcription. 
Results 
DSBs inhibit Rag1 and Rag2 transcription, while mRNA turnover is mostly unaffected  
 In most identified cases, regulation of Rag1 and Rag2 mRNA occurs through 
transcriptional regulation. However, steady state mRNA levels can be regulated either 
by changes in input or outflow, ie either by changes in transcription or degradation. 
Therefore, the decreased total mRNA levels upon DSBs exposure shown in Chapter 2 
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could be caused either by decreased Rag1 and Rag2 transcription or increased 
degradation of these mRNAs. To identify the mechanism by which DSBs suppress Rag1 
and Rag2 expression, we measured turnover and transcription of these mRNAs in either 
irradiated or unirradiated IL-7 withdrawn pre-B cells. For these experiments we used 
Click-iT® technology, in which cells are cultured in media containing ethyl uridine (EU); 
EU is incorporated into mRNA transcripts generated in its presence, and can be 
specifically pulled down so that labeled RNA can be measured by qPCR.  
 To measure mRNA turnover, EU was added to the media of IL-7 withdrawn ex 
vivo pre-B cells for 16 hours, and then washed out immediately before the cells were 
either exposed to 4 Gy IR or left unexposed to IR. Loss of labeled transcripts over time 
was measured by qPCR. Half-life was determined by normalizing the values measured 
for labeled Rag1 and Rag2 mRNAs to labeled 18S RNA, which has a long half-life and 
therefore undergoes negligible degradation within the timecourse of our assay. We 
found that the half-life of both Rag1 and Rag2 mRNAs in unirradiated cells was about 40 
minutes (Fig. 3.1a), similar to previously published results using nuclear run-on assays 
(Verkoczy et al., 2005). IR did not change the half-life of Rag1 mRNA, while the half-life 
of Rag2 mRNA decreased modestly, by approximately 25% (Fig. 3.1a). A 25% decrease in 
Rag2 mRNA half-life is not sufficient to explain the rapid (<1hour) and substantial (80%) 
decrease in total Rag2 mRNA measured in these circumstances (see figure 2.1a).  
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 To measure transcription, EU was added to the media of IL-7 withdrawn ex vivo 
pre-B cells immediately after these cells were either exposed to 4Gy IR or left 
unirradiated. The accumulation of new labeled transcripts was measured by qPCR and 
normalized to values measured for EU-labeled Hprt, a transcript we do not expect to be 
affected by IR. These data are presented as the ratio of new Rag1 or Rag2 transcripts in 
irradiated vs. unirradiated transcripts; a ratio of 1 would indicate that IR has no effect on 
transcription. As shown in Fig. 3.1b, by 45 minutes after irradiation irradiated cells have 
produced significantly less new Rag1 and Rag2 mRNA than unirradiated cells, and a 
trend in this direction can be observed as early as 30 minutes after irradiation. This 
demonstrates a rapid and profound decrease in transcription of both the Rag1 and Rag2 
genes following IR exposure. Therefore, we conclude that transcription is the major 
mechanism through which DSBs suppress Rag1 and Rag2 mRNA expression, and 
regulation of mRNA turnover does not play a major role. 
 Although these results show that Rag1 and Rag2 mRNA transcription is 
profoundly reduced following IR of ex vivo cultured primary pre-B cells, it is formally 
possible that this is not because Rag1 and Rag2 transcription is specifically targeted by 
the DNA damage response (DDR), but rather because the extreme stress caused by 
exposure to a high dose of IR leads to a general transcriptional repression of genes not 
required for the DDR. One piece of evidence against this scenario is that the values for 
newly transcribed Rag1 and Rag2 mRNA are normalized to newly transcribed Hprt 
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mRNA; if all of these mRNAs were affected by a general transcriptional repression, then 
there would be no apparent difference in the normalized values of irradiated and 
unirradiated samples. Of course Hprt might be an exception, and so we also measured 
transcription of another gene that is not required for the DDR, Wasp. We found that 
irradiation caused a modest decrease in accumulation of new Wasp transcripts, but this 
decrease was slower and much less profound than the decrease observed for Rag1 and 
Rag2 transcripts (Fig. 3.1b). These data support our hypothesis that Rag1 and Rag2 
expression is specifically targeted by the DDR in pre-B cells. 
Suppression of Rag1 and Rag2 mRNA by DSBs does not require new protein synthesis 
 In broad terms, DSBs could suppress Rag1 and Rag2 transcription either by 
increasing the expression and/or activity of a transcriptional repressor, or by decreasing 
the expression and/or activity of a transcriptional activator. However, the speed with 
which DSBs suppress Rag1 and Rag2 transcription suggests that the mechanism does 
not require the synthesis of a new repressor, as this would be likely to act more slowly. 
To test this directly, we treated IL-7 withdrawn and irradiated pre-B cells with 
cycloheximide to determine whether new protein synthesis was required for 
suppression of Rag1 and Rag2 transcription by DSBs. Cycloheximide treatment without 
IR lead to an increase in Rag1 and Rag2 mRNA expression (Fig. 3.2a), as previously 
reported (Verkoczy et al., 2005). However, cycloheximide treatment did not prevent the 
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suppression of Rag1 and Rag2 mRNA expression by IR (Fig. 3.2a). This result indicates 
that the suppressive signal acts through factors that are present in undamaged cells, 
and does not require the synthesis of a new transcriptional inhibitor. 
Suppression of Rag1 and Rag2 mRNA by DSBs does not require protein degradation 
 We next tested whether protein degradation was required for the suppression of 
Rag1 and Rag2 mRNA expression by DSBs, as we would expect to be the case if the 
signal depended on loss of a transcriptional activator. We find that suppression of Rag1 
and Rag2 mRNA is unaffected by the proteosome inhibitor Mg132 (Fig. 3.2b). This 
results shows that protein degradation is not absolutely required for inhibition of Rag1 
and Rag2 transcription by DSBs. However, it is possible that the activity of a 
transcriptional activator might be suppressed by post-translational modification rather 
than by degradation. 
ATM activity is required for suppression of Rag1 and Rag2 expression by DSBs 
 Having established general rules that the suppression of Rag1 and Rag2 
expression by DSBs seems to follow, we investigated the involvement of specific 
signaling pathways. Because RAG-mediated DSBs act through ATM to suppress Rag1 and 
Rag2 mRNA expression (Steinel et al., 2013), we tested ATM's role in the response to IR-
induced DSBs. We first determined the effect of ATM inhibition on DSB-mediated 
suppression of Rag1 and Rag2 mRNA expression in ATM-sufficient IL-7 withdrawn 
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primary pre-B cells. Either the ATM inhibitor KU55933 or vehicle control was added to 
these cells at the same time as IL-7 withdrawal. 48 hours later, these cells were either 
exposed to 4 Gy IR or left unirradiated. ATM inhibition led to increased basal Rag1 and 
Rag2 mRNA expression in unirradiated cells. More importantly, ATM inhibition 
completely prevented the suppression of Rag1 and Rag2 mRNA expression caused IR 
(Fig. 3.3a). ATM inhibition also prevented the loss of Rag1 protein expression that 
normally occurs after exposure to IR (Fig. 3.3b). To further confirm the role of ATM in 
suppression of Rag1 and Rag2 mRNA expression, we exposed Mb1cre+ Atmf/f IL-7 
withdrawn pre-B cells to 4 Gy IR and compared their Rag1 and Rag2 expression to 
unirradiated controls. We found that IR exposure does not decrease Rag1 or Rag2 
mRNA expression in ATM-deficient cells, in contrast to the suppression observed in 
EμBCL+ ATM-sufficient cells. Collectively, these data show that DSBs act through the 
DNA-damage response protein ATM to suppress Rag1 and Rag2 mRNA expression, 
leading to decreased Rag1 protein expression. 
Suppression of Gadd45α expression is not required to suppress Rag1 and Rag2 mRNA 
expression 
 Previous work from the Bassing laboratory showed that RAG-mediated DSBs 
suppress expression of Gadd45α mRNA and protein via ATM activity (Steinel et al., 
2013). Because other work showed that Gadd45α can indirectly regulate Rag1 and Rag2 
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transcription by promoting activation Foxo1 activity (Amin and Schlissel, 2008), we 
hypothesized that DSBs suppress Rag1 and Rag2 expression by decreasing Gadd45α 
expression. However, we found that IR only modestly suppressed Gadd45α mRNA 
expression, by about 50% (Sup. Fig. 3.1a). Furthermore, although Gadd45α transcription 
was decreased by IR, this decrease occurred more slowly than the decrease in Rag1 and 
Rag2 transcription (compare Fig. 3.2 and Sup. Fig. 3.1b). Finally, we performed several 
experiments in which Gadd45α was constitutively expressed in a variety of conditions, 
including using either an unmodified Gadd45α construct or a tamoxifen-inducible 
version, and using either primary pre-B cells or Abelson-transformed pre-B cell line. Sup. 
Fig. 3.1c shows the results of a representative experiment in which EμBCL2+ Abelson 
cells were transduced either with empty vector or ER-Gadd45α. These cells were then 
treated with tamoxifen and 2 hours later exposed to 4Gy IR or unexposed. In this 
experiment, as in all conditions tested, we found that Gadd45α overexpression had no 
effect on either basal Rag1 and Rag2 mRNA expression or in the suppression caused by 
IR. Therefore, we believe that the decrease in Gadd45α expression caused by both RAG-
mediated and IR-induced DSBs is coincidental, and does not mediate suppression of RAG 
expression. 
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Activation of Nemo is required for optimal suppression of Rag1 and Rag2 by DSBs 
 Although ATM has many substrates and orchestrates a complex network of 
responses to DSBs, two important branches of this signaling network act through p53 
and Nemo (Miyamoto, 2011; Shiloh and Ziv, 2013). Therefore, we next investigated the 
roles of p53 and Nemo in suppressing Rag1 and Rag2 expression following the induction 
of DSBs in primary pre-B cells. To determine whether Nemo or p53 is required for 
suppression of Rag1 and Rag2 expression by DSBs, we exposed cells deficient for each 
factor to 4 Gy IR and compared their Rag1 and Rag2 mRNA expression to unirradiated 
cells. We observed normal downregulation of Rag1 and Rag2 mRNAs following 
irradiation of primary pre-B cells cultured from VavCre+Tp53flox/flox mice with 
hematopoietic lineage-specific deletion of p53 (Sup. Fig. 3.2). In contrast, EμBCL+ 
Mb1cre+ Nemof/f IL-7 withdrawn pre-B cells did not suppress Rag1 and Rag2 mRNA 
expression as efficiently as wild-type cells. Although Rag1 and Rag2 mRNA expression is 
lower in irradiated Nemo-deficient cells than in unirradiated cells at 1 hour after 
exposure, the decrease is less than that seen in Nemo-sufficient cells (Fig. 3.4a&b). By 4 
hours after IR exposure, Rag1 and Rag2 mRNA expression in irradiated Nemo-deficient 
cells recovers to normal levels, while expression in Nemo-sufficient cells is still repressed 
this timepoint (compare Fig. 3.4a and Fig. 2.1a). The partial suppression observed 1 hour 
after IR exposure suggests that a Nemo-independent mechanism may act very early to 
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suppress Rag1 and Rag2 expression. However, Nemo is absolutely required for 
sustained suppression of Rag1 and Rag2 mRNA expression by DSBs. 
Activation of IKKα/β in pre-B cells exposed to IR 
 In most documented cases, Nemo regulates gene expression by allowing 
activation of canonical NF-κB signaling pathway (Miyamoto, 2011). DNA damage has 
been shown to activate NF-κB signaling in many cell and tissue types, including whole 
bone marrow and pre-B cell lines (Zhou et al., 1999; Bredemeyer et al., 2008). One of 
the hallmarks of NF-κB activation is phosphorylation of the key kinases IKKα (which 
activates the non-canonical pathway) or IKKβ (which activates the canonical pathway). 
To determine whether IL-7 withdrawn pre-B cells exposed to IR activate this pathway 
within the timeframe that Rag1 and Rag2 expression are repressed, we measured 
accumulation of phospho-IKK. The antibodies used bind both IKKα and IKKβ. Because 
these two kinases have a similar molecular weight, we cannot distinguish between them 
in this experiment. We found that phospho-IKKα/IKKβ accumulates as early as 30 
minutes after IR exposure and persists for at least 60 minutes (Sup. Fig. 3.3). Notably, 
phospho-IKKα/IKKβ is completely lost by 4 hours after IR exposure, although Rag1 and 
Rag2 mRNA expression are still suppressed at this point (compare Sup. Fig. 3.3 and Fig. 
2.1a). Therefore if NF-κB signaling is required for suppression of Rag1 and Rag2 mRNA 
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expression, the suppressive effect can persist for some time after active signaling is 
terminated. 
Two IKK inhibitors have different effects on basal Rag1 and Rag2 expression and 
response to DSBs. 
 As noted above, the most prominent role for Nemo in cell biology is through its 
involvement in canonical NF-κB signaling. In the absence of Nemo, IKKβ is unable to 
phosphorylate IκBα and activate NF-κB activity (Rudolph et al., 2000; Schröfelbauer et 
al., 2012). Therefore, we hypothesized that lack of IKKβ activity would have a similar 
effect on Rag1 and Rag2 mRNA expression as Nemo deficiency. We initially chose the 
IKK inhibitor BMS-345541 because a recent paper showed that this inhibitor could act 
synergistically with Akt inhibition to activate Rag1 mRNA expression in Abelson-
transformed cells without sti571 treatment, a circumstance in which Rag1 expression is 
normally strongly suppressed (Ochodnicka-Mackovicova et al., 2015). We first pre-
treated IL-7 withdrawn EμBCL2+ primary-pre-B cells with BMS-345541; after 2 hours the 
culture was split and either exposed to 4 Gy IR or unirradiated. To our surprise, BMS-
345541 treatment alone inhibited Rag2 mRNA expression to approximately the same 
extent as IR alone; there was no significant additional effect with combined BMS-
345541 treatment and IR (Fig. 3.5a). We also found a trend towards decreased Rag1 
mRNA expression in the BMS-345541 treated cells (Fig. 3.5a). However whereas IR had a 
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negligible effect on Rag2 expression in BMS-345541 treated cells, Rag1 expression 
appeared to follow a pattern similar to that in Nemo-deficient cells, in which Rag1 
expression first decreases modestly and then recovers to normal levels (compare Fig. 
3.5a and Fig. 3.4a).  
 Notably, BMS-345541 inhibits IKKα as well as IKKβ, although the IC50 for IKKα 
inhibition is approximately an order of magnitude greater (Burke et al., 2003). 
Therefore, we considered that our results using BMS-345541 might be confounded by 
inhibition of non-canonical NF-κB pathway in addition to the canonical pathway. To 
address this issue, we repeated these experiments using the inhibitor ML120B, which 
selectively inhibits IKKβ and has no effect on IKKα even at high doses (Nagashima et al., 
2006). In contrast to BMS-345541, treatment with ML120B caused a trend towards 
increased Rag1 and Rag2 mRNA expression (Fig. 3.5b). When ML120B-treated pre-B 
cells were exposed to IR, they experienced an early decrease in Rag1 and Rag2 mRNA 
expression but began to recover by 4 hours after IR exposure; cells without the inhibitor 
still showed strong suppression of Rag1 and Rag2 mRNA expression at this time point 
(Fig. 3.5b). This is very similar to the effect of Nemo-deficiency, consistent with the 
hypothesis that Nemo regulates Rag1 and Rag2 expression through its ability to 
potentiate IKKβ activity.  
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Nfkb1/p50 is not required for suppression of Rag1 and Rag1 mRNA by DSBs 
 Of the five NF-κB family transcription factors, only p50 has been specifically 
shown to have any effect on Rag1 and Rag2 expression; p50 knockout pre-B cells have 
approximately 3-fold higher Rag1 and Rag2 mRNA levels than wild-type cells (Verkoczy 
et al., 2005). As this data suggests that p50 normally has a suppressive effect on Rag1 
and Rag2 expression, we hypothesized that p50-deficient pre-B cells would be unable to 
suppress Rag1 and Rag2 expression in response to DSBs. Because NF-κB signaling 
normally promotes cell survival, we were concerned that the p50-deficient cells would 
not survive the week-long culture used in most of our ex vivo pre-B cell experiments. 
Therefore, we isolated total BM from Nfkb1-/- mice and pre-incubated them for only 2 
hours before splitting the cells from each mouse into two pools, either unirradiated or 
exposed to 4 Gy IR; RNA was collected from each pool 4 hours after IR exposure. Rag1 
and Rag2 expression decreased in the p50-/- BM to a similar extent as in wild-type pre-B 
cell cultures (Fig. 3.5c). We conclude that p50 is not required for normal suppression of 
Rag1 and Rag2 mRNA expression in developing B cells. 
LPS treatment suppresses Rag1 and Rag2 mRNA expression 
 The role of Nemo and IKKβ in suppressing Rag1 and Rag2 expression in response 
to DSBs led us to wonder whether stimuli that activate NF-κB signaling independent of 
ATM activity would also suppress Rag1 and Rag2 expression. To test this we exposed IL-
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7 withdrawn pre-B cells to LPS, a potent inducer of NF-κB activity in pre-B cells (Sen and 
Baltimore, 1986). LPS treatment suppressed Rag1 and Rag2 mRNA expression 
approximately 80% within 4 hours of exposure. This is similar to the reduction caused by 
IR, etoposide, or bleomycin. These results show that DSBs are not the only stimulus that 
can suppress Rag1 and Rag2 expression, and are consistent with a central role for NF-κB 
signaling in this pathway. However, both DSBs and LPS activate a multitude of 
intracellular signaling pathways, and so additional work will be necessary to confirm the 
importance of NF-κB factors in response to each stimulus. 
Discussion 
 These studies show that suppression of Rag1 and Rag2 mRNA expression by 
DSBs depends on rapid inhibition of Rag1 and Rag2 transcription. This inhibition 
requires neither new protein synthesis nor protein degradation, suggesting that the 
mechanism does not require production of a new transcriptional activator or 
destruction of an existing transcriptional activator. We found that the DNA damage 
response protein ATM is absolutely required for suppression of Rag1 and Rag2 mRNA 
expression by DSBs. Nemo and IKKβ, upstream activators of canonical NF-κB signaling, 
are also required for maximal suppression of Rag1 and Rag2 expression by DSBs. 
However, the limited suppression observed in the absence of these factors suggests that 
a second, more transient mechanism may also be involved in suppression of Rag1 and 
Rag2 expression. Finally, the ability of LPS stimulation, like DSBs, to suppress Rag1 and 
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Rag2 expression suggests that other stimuli can activate NF-κB signaling to suppress 
Rag1 and Rag2 expression. 
 Several studies have implicated ATM in regulating V(D)J recombination to 
promote mono-allelic rearrangement of antigen receptor alleles. Previous work from 
the Bassing laboratory showed that RAG-mediated DSBs activate ATM and suppress 
Rag1 and Rag2 expression (Steinel et al., 2013). The experiments presented in this 
dissertation show that this signal is not unique to RAG-mediated DSBs, but rather can be 
activated by DSBs induced by a variety of agents. This signal represents a highly cell-type 
specific application of a ubiquitous DDR factor conserved from yeast to mammals, 
highlighting the ability of evolution to employ ancient systems for new functions. 
 The Bassing laboratory previously showed that RAG-mediated DSBs suppress 
expression of Gadd45α, a factor which had been shown to promote Rag1 and Rag2 
expression by increasing Foxo1 activity (Amin and Schlissel, 2008; Steinel et al., 2013). 
However, the work presented here does not support a role for Gadd45α in suppressing 
Rag1 and Rag2 transcription. Gadd45α overexpression was not able to prevent 
suppression of Rag1 and Rag2 expression; we found similar results when over-
expressing Foxo1 (data not shown). Admittedly, these experiments cannot rule out the 
possibility that post-translational modifications inhibit Gadd45α or Foxo1 activity; 
indeed, it is well known that Foxo1 activity and stability in is inhibited through 
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phosphorylation by Akt (Tzivion et al., 2011; Verkoczy et al., 2007; Amin and Schlissel, 
2008). A recent study confirmed many of our central findings regarding the ability of 
DSBs to suppress Rag1 and Rag2 expression via ATM activity in pre-B cell lines. 
Additionally, this group found that DSBs lead to Foxo1 protein degradation and loss of 
Foxo1 binding to the Erag enhancer in B-ALL cell lines (Ochodnicka-Mackovicova et al., 
2016). However, we find no decrease in Foxo1 protein or increase in Foxo1 
phosphorylation in primary pre-B cells exposed to IR (data not shown). Although we 
have not assayed Foxo1 binding to the Rag1/Rag2 gene locus, our data suggest that the 
regulation of Foxo1 in primary pre-B cells does not completely recapitulate the 
regulation found in B-ALL cell lines. However, it is possible ATM activates two diverging 
pathways activating Nemo and inhibiting Foxo1 binding to the Rag1 and Rag2 locus, and 
that both pathways contribute to optimal suppression of Rag1 and Rag2 expression. 
This scenario could explain the limited suppression of Rag1 and Rag2 mRNA expression 
we find in Nemo-deficient mice. 
 The effect of NF-κB activity on Rag1 and Rag2 expression has been controversial, 
perhaps partially because of the complexity of NF-κB signaling itself. One widely-cited 
study found IgM crosslinking in immature B cells increases Rag1 and Rag2 expression by 
activating NF-κB factors. However, the same study found that Nfkb1 knockout cells have 
increased Rag1 and Rag2 expression; the authors suggested that transcriptionally 
inactive p50/p50 homodimers might compete with transcriptionally active p65 and c-Rel 
78 
 
containing complexes (Verkoczy et al., 2005). Several studies find that DN IκBα, which 
inhibits canonical NF-κB activation, has no effect on Rag1 and Rag2 expression in pre-B 
cells (Amin and Schlissel, 2008; Cadera et al., 2009). On the other hand, inhibition of 
IKKβ increased Rag1 expression in certain pre-B cell lines (Ochodnicka-Mackovicova et 
al., 2015). 
 Here, we add to this confusing mess of data points by showing that Nemo and 
IKKβ participate in suppressing Rag1 and Rag2 expression in pre-B cells exposed to 
DSBs. Furthermore, we found that an IKKα/IKKβ inhibitor seriously impaired Rag2 
expression but had little effect on basal Rag1 expression, a notable exception to the 
general rule that expression of Rag1 and Rag2 mRNAs are coordinately regulated. In 
contrast, an IKKβ-specific inhibitor does not suppress, and may even increase, Rag1 and 
Rag2 mRNA expression. Although only specific NF-κB transcription factor tested, 
Nfkb1/p50, was not required for suppression of Rag1 and Rag2, this does not rule out a 
role for NF-κB signaling as other NF-κB factors are still active in these cells (Sha et al., 
1995).  
 Together, these results suggest several potential explanations for the confusion 
in the literature. First, apparently contradictory findings might be due to the different 
methods used to manipulate NF-κB, which affect different steps of NF-κB activation and 
may have narrower or broader effects on the various NF-κB homo- and heterodimers 
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and the IkB factors that regulate them. Indeed, our IKK inhibitor experiments suggest 
that IKKα and IKKβ activity might have opposing effects on Rag1 and Rag2 expression. 
Secondly, most of this activity seems to be induced by stimulus-induced, and may be 
less important under normal conditions; this would explain the lack of effect previously 
seen on basal Rag1 and Rag2 expression. Additionally, the expression of many NF-κB 
factors and their regulatory proteins is known to change throughout B cell development, 
particularly at the pre-B to immature B transition (Sup. Fig. 3.4 and Kistler et al., 1998). 
This raises the possibility that NF-κB activity might have different effects on Rag1 and 
Rag2 activity depending on the developmental stage of the cell. 
 Although the bulk of this our work focuses on the effect of DSBs on Rag1 and 
Rag2 expression, the apparent involvement of NF-κB factors led us to question whether 
other stimuli that activate NF-κB signaling would also suppress Rag1 and Rag2 
expression in pre-B cells. Indeed, we find that exposure to the bacterial endotoxin LPS 
suppresses Rag1 and Rag2 mRNA expression. LPS is an inflammatory stimulus, and it has 
been thoroughly documented that inflammation suppresses B cell development at 
multiple stages (Cain et al., 2009). It will be important to confirm that NF-κB factors play 
a role in the suppression of Rag1 and Rag2 expression by LPS, and determine whether 
other inflammatory stimuli have a similar effect. Interestingly, it was recently shown 
that chronic inflammation can suppress Rag1 expression in the common lymphoid 
progenitor, the earliest developmental stage in which it is normally expressed (Baratono 
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et al., 2015). In itself, the ability of LPS to suppress Rag1 and Rag2 mRNA expression 
simply tells us that DSBs are not unique in their ability to suppress Rag1 and Rag2 
expression. Of course, these two stimuli are very different in nature. DSBs represent a 
threat within the developing lymphocyte itself; as discussed in Chapter 2, initiation of 
V(D)J recombination in the presence of DSBs might lead to oncogenic antigen receptor 
translocations. LPS and other inflammatory stimuli do not necessarily represent a threat 
to the health of an individual lymphocyte, but rather to the larger organism. Therefore 
on a more speculative level, our results suggests that two quite different "danger" 
stimuli activate a conserved pathway to suppress Rag1 and Rag2 expression in 
situations where V(D)J recombination may be undesirable. 
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Figure 3.1 
 
 
Figure 3.1: DSBs cause a rapid and specific decrease in Rag1 and Rag2 transcription. (A) 
qRT-PCR quantification of EU-labeled Rag1 and Rag2 mRNA levels relative to EU-labeled 
18S RNA levels in non-irradiated or irradiated EμBCL2 pre-B cells at indicated times after 
EU washout and/or exposure to 4 Gy of IR. Data are from 4 independent experiments. 
Data averages are shown with error bars the SEM. Prism 5 was used to calculate best-fit 
curves, half-lives and p-values. ***p<0.001. (B) qRT-PCR quantification of EU-labeled 
Rag1, Rag2, and Wasp mRNA levels relative to EU-labeled Hprt mRNA levels in non-
irradiated or irradiated EμBCL2 pre-B cells at indicated times after addition of EU and 
exposure to 4 Gy of IR. Data are presented as the ratio of relative levels of each mRNA in 
irradiated cells compared to non-irradiated cells. The gray line represents a value of 1, 
which would indicate that IR had no effect on the transcription rate of a gene. Data are 
from 4 independent experiments. p-values for whether the average ratio at each time 
point is different from 1.0 was determined using one-tailed T test with Bonferroni's 
correction for multiple testing. 
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Figure 3.2 
 
Figure 3.2: DSBs do not require new protein synthesis or protein degradation to 
suppress Rag1 and Rag2 mRNA expression. (A) qRT-PCR quantification of Rag1 and 
Rag2 mRNA in EμBCL2 pre-B cells treated with cycloheximide and then not irradiated 
exposed to 4 Gy IR. Data are from 3 independent experiments. (B) qRT-PCR 
quantification of Rag1 and Rag2 mRNA in EμBCL2 pre-B cells treated with mg132 or 
vehicle control and non-irradiated or irradiated with 4 Gy IR at indicated times after 
exposure IR. Data are from 3 independent experiments. (A&B) Data averages are shown 
with error bars the SEM. p-values were calculated by T test with Bonferroni's correction 
for multiple testing. 
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Figure 3.3 
 
Figure 3.3: ATM is required for DSBs induced in pre-B cells to downregulate Rag1 and 
Rag2 expression. (A) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in non-
irradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy of 
IR. Cells were treated with 15 μM of the KU55933 ATM kinase inhibitor or vehicle 
(DMSO) for 48 hours prior to irradiation or harvesting of non-irradiated cells. Data are 
from 8 independent experiments. (B) Representative western blot and quantification 
from experiment described in (A). (C) qRT-PCR quantification of Rag1, Rag2, and p21 
mRNA in non-irradiated or irradiated Mb1Cre+Atmflox/flox pre-B cells at indicated times 
after exposure to 4 Gy IR. Data are from 3 independent experiments. (A-C) Data are 
normalized to 1.0 for non-irradiated cells harvested one hour following IR exposure of 
irradiated samples. For other samples, data averages are shown with error bars 
indicating SEM. p-values were calculated by Dunnett's post-test after ANOVA. 
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Figure 3.4 
 
Figure 3.4: Nemo is required for pre-B cells to normally downregulate Rag1 and Rag2 
expression in response to DSBs. (A) qRT-PCR quantification of Rag1, Rag2, and p21 
mRNA in non-irradiated Mb1Cre+Nemoflox/floxEμBCL2 pre-B cells or irradiated 
Mb1Cre+Nemoflox/floxEμBCL2 pre-B cells at indicated times after exposure to 4 Gy IR. Data 
are from 3 independent experiments. p-values were calculated by Dunnett's post-test 
after ANOVA. (B) qRT-PCR quantification of Rag1 and Rag2 mRNA in non-irradiated or 
irradiated pre-B cells from EμBCL2 or Mb1Cre+Nemoflox/floxEμBCL2 mice at 1 hour after 
exposure to 4 Gy IR. Data are from 3 independent experiments. p-value was calculated 
by T test. (A&B) Data are normalized to 1.0 for non-irradiated cells harvested one hour 
following IR exposure of irradiated samples. For other samples, data averages are shown 
with error bars indicating SEM.  
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Figure 3.5 
 
Figure 3.5: Variable effects of IKK inhibitors on basal Rag1 and Rag2 expression and on 
suppression by DSBs. (A) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in non-
irradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy of 
IR. Cells were treated with 5 μM BMS-345541 IKK kinase inhibitor or vehicle (DMSO) for 
2 hours prior to irradiation. Data are from 3 independent experiments. (B) qRT-PCR 
quantification of Rag1, Rag2, and p21 mRNA in non-irradiated or irradiated EμBCL2 pre-
B cells at indicated times after exposure to 4 Gy of IR. Cells were treated with 10 μM of 
the ML120B IKKβ kinase inhibitor or vehicle (DMSO) for 2 hours prior to irradiation. Data 
are from 3 independent experiments. (C) qRT-PCR quantification of Rag1, Rag2, and p21 
mRNA in BM from NF-κB1-/- mice. BM was harvested and pre-incubated for 2 hours at 
37°. After pre-incubated, BM from each mouse was divided into two samples and either 
unirradiated or exposed to 4 Gy IR; RNA was collected 4 hours later. Data are from one 
experiment with 4 mice.  
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Figure 3.6 
 
Figure 3.6: LPS treatment suppresses Rag1 and Rag2 mRNA in a manner similar to DSBs. 
qRT-PCR quantification of Rag1 and Rag2 mRNA in EμBCL2 pre-B cells treated with 15 
μg/mL LPS or vehicle (water) for the indicated time periods. Data are from 3 
independent experiments. 
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Supplemental Figure 3.1 
 
Sup. Fig. 3.1: Constitutive Gadd45α expression does not prevent suppression of Rag1 
and Rag2 mRNA expression by DSBs. (A) qRT-PCR quantification of Gadd45α mRNA in 
non-irradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy 
IR. Data are from 11 independent experiments. Data are normalized to 1.0 for non-
irradiated cells. For irradiated cells, data averages are shown with error bars indicating 
SEM. p-values calculated using Dunnett's post-test after ANOVA. ***p<0.001. (B) qRT-
PCR quantification of EU-labeled Gadd45α mRNA levels relative to EU-labeled Hprt 
mRNA levels in non-irradiated EμBCL2pre-B cells and irradiated EμBCL2 pre-B cells at 
indicated times after addition of EU and exposure to 4Gy of IR. Data are presented as 
the ratio of relative levels of each mRNA in irradiated cells compared to non-irradiated 
cells. The dotted line represents a value of 1, which would indicate that IR had no effect 
on the transcription rate of an assayed gene. Data are from 4 independent experiments. 
p-values were determined using one-tailed T test with Bonferroni's correction for 
multiple testing. ***p<0.001.(C) qRT-PCR quantification of Rag1 and Rag2 mRNA in non-
irradiated and irradiated Rag1D708A Abl pre-B cells transduced with an empty retroviral 
vector or the same retroviral vector containing an ERGadd45α cDNA. For 2 hours before 
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harvesting non-irradiated cells or exposing to IR the irradiated cells, all cells were 
treated with tamoxifen to induce nuclear translocation of ER-Gadd45α. Data are from 
one representative experiment. (D) Western blot showing ER-Gadd45α and actin 
expression in Rag1D708A Abl pre-B cells transduced with an empty retroviral vector or the 
same retroviral vector containing an ER-Gadd45α cDNA. Data are from one experiment. 
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Supplemental Figure 3.2 
 
Sup. Fig. 3.2: p53 activity is not required for suppression of Rag1 and Rag2 mRNA 
expression by DSBs. qRT-PCR quantification of Rag1 and Rag2 mRNA in non-irradiated 
VavCre+Tp53flox/flox pre-B cells or irradiated VavCre+Tp53flox/flox pre-B cells at indicated 
times after exposure to 4 Gy IR. Data are from 2 independent experiments. Data are 
normalized to 1.0 for non-irradiated cells harvested one hour following IR exposure of 
irradiated samples. For other samples, data averages are shown with error bars 
indicating SEM. 
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Supplemental Figure 3.3 
 
Sup. Fig. 3.3: Phosphorylated IKKα/IKKβ accumulates rapidly and transiently in IL-7 
withdrawn pre-B cells in response to DSBs. Western blot showing phosphorylated and 
total IKKα/IKKβ in unirradiated pre-B cells or pre-B cells exposed to 4 Gy IR. The 
antibodies used cannot distinguish between IKKα and IKKβ. 
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Supplemental Figure 3.4 
 
Sup. Fig. 3.4: Expression of factors involved in NF-κB signaling changes throughout B cell 
development. The heatmap was generated using "my dataset" tool in the Immgen 
database (www.immgen.org). All BM B cell subsets and an early splenic subset (T1) were 
used to generate the heatmap. The list of factors involved in NF-kB signaling was based 
on a comprehensive review of NF-kB published in 2012 (Hayden and Ghosh, 2012). 
92 
 
Chapter 4: Impact of DSB signaling on allelic exclusion1 
Abstract 
 Chapters 2 and 3 described the ability of exogenously induced DSBs to activate 
ATM and Nemo to suppress Rag1 and Rag2 expression in pro-B cells, pre-B cells, and DN 
thymocytes. A similar suppressive signal activated by RAG cleavage in pre-B cells had 
previously been correlated with increased Igκ allelic inclusion. Here, we show that ATM 
also regulates allelic exclusion of the IgH chain rearranged in pro-B cells and the TCRβ 
chain rearranged in DN thymocytes. Increased TCRβ allelic inclusion is established early 
in T cell development and is correlated with an increased frequency of T cells containing 
two TCRβ rearrangements, indicating a failure of allelic exclusion at level of TCRβ 
rearrangement. We also investigated the role of several factors proposed to cooperate 
with or act downstream of ATM in promoting allelic exclusion. We found that the cell 
cycle regulator cyclin D3 has only a minor role in Igκ allelic inclusion despite its more 
prominent role in IgH and TCRβ allelic inclusion. Spi-C, which has been proposed to 
suppress Igκ locus accessibility in the presence of DSBs, was found to be unnecessary for 
allelic exclusion. In contrast, we find that Nemo-deficient B cells have increased Igκ 
                                                      
1 Parts of this chapter were published in The Journal of Immunology. Copyright © 2014 The American 
Association of Immunologists, Inc. Steinel NC, Fisher MR, Yang-Iott KS, Bassing CH. The Ataxia 
Telangiecetasia Mutated and Cyclin D3 Proteins Cooperate to Help Enforce TCRβ and IgH Allelic Exclusion. 
J. Immunol. 193:2881-2890. Portions of this chapter were prepared jointly with Natalie Steinel. 
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allelic inclusion, further supporting a role for Nemo-mediated suppression of Rag1 and 
Rag2 expression in promoting allelic exclusion. 
Introduction 
 Even before the discovery of V(D)J recombination, it was recognized that each B 
cell expresses only one IgH and one IgL chain on their cell surface, despite the 
availability of multiple alleles; this phenomenon is known as allelic exclusion (Bernier 
and Cebra, 1964; Pernis et al., 1965). At a genetic level, it was found that B cells typically 
contain only one productively rearranged IgH gene and one functional IgL gene, while T 
cells have only one productively rearranged TCRβ gene (Alt et al., 1980, 1984; Casanova 
et al., 1991). However, the TCRα chain does not appear to be allelically excluded at 
either the level of genetic rearrangement or cell surface expression (Casanova et al., 
1991; Heath et al., 1995). 
 If allelic exclusion did not occur at the genetic level, it would be predicted that 
V(D)J 100% of cells would contain two rearrangements for each antigen receptor chain, 
and that many cells would contain two productive rearrangements. For IgH and TCRβ 
loci the upper limit of cells that could contain two productive rearrangements is 20%, as 
2/3 of all rearrangements are out-of-frame, and each IgH or TCRβ allele can undergo 
rearrangement only once. On the other hand, if allelic exclusion operated perfectly at 
the genetic level, it would be predicted that approximately 60% of B and T cells would 
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have only one fully rearranged IgH or TCRβ gene (Alt et al., 1984; Malissen et al., 1992). 
By definition, 0% of those lymphocytes would contain two productive rearrangements 
for the same antigen receptor gene in this case. In fact, IgH, Igκ, and TCRβ 
rearrangements show strong evidence for allelic inclusion at the genetic level, in that 
close to 60% of B and T cells contain only 1 rearranged IgH or TCRβ allele, and very few 
lymphocytes contain two productive rearrangements for the same antigen receptor 
chain (Alt et al., 1984; Casanova et al., 1991). However, allelic inclusion at the genetic 
level is generally somewhat higher than inclusion at the level of cell surface antigen 
receptor expression. Factors accounting for this gap include the requirement for pairing 
of IgH and IgL or TCRβ and TCRα chains and post-transcriptional silencing of one allele 
(Brady et al., 2010) 
 Several mechanisms cooperate to enforce allelic exclusion of antigen receptor 
gene rearrangements. Most famous is feedback inhibition by the protein products of 
functionally rearranged antigen receptor genes. These proteins assemble into cell 
surface complexes that generate signals to inhibit subsequent gene rearrangement. In 
pro-B cells that create a productive IgH rearrangement, the new IgH chain pairs with 
surrogate light chains (VpreB and λ5) and the signaling components of the BCR (Igα and 
Igβ) to form the pre-BCR; inability of this heavy chain to signal prevents feedback 
inhibition and allows cells to create multiple productive IgH rearrangements (Kitamura 
and Rajewsky, 1992; Papavasiliou et al., 1995; Schweighoffer et al., 2003). Similarly, 
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creation of a functional light chain in pre-B cells allows cell surface expression of the 
complete BCR, which signals feedback inhibition of further Igκ or Igλ rearrangement 
(Grawunder et al., 1995). A similar situation is found in DN thymocytes; a newly 
synthesized TCRβ chain pairs with the pre-Tα chain to form the pre-TCR, and inability of 
the pre-TCR to signal leads to the generation of cells with two productive TCRβ alleles 
(Aifantis et al., 1997, 1999). The feedback signal acts both by turning off RAG expression 
(Grawunder et al., 1995; Hoffman et al., 1996; Li et al., 1993), and by alterations in 
chromatin structure and 3D DNA organization of the excluded locus to preclude RAG 
activity (Corcoran, 2005; Roldán et al., 2005; Kondilis-Mangum et al., 2011). 
 It is important to note that feedback inhibition can only prevent allelic inclusion 
if rearrangements do not occur simultaneously. Indeed, several studies using FISH and γ-
H2AX staining to mark antigen receptor loci with DSBs show that normally, only one 
cleaved allele exists in a cell (Hewitt et al., 2009; Chaumeil et al., 2013; Chan et al., 
2013). The Bergman laboratory has provided evidence that one of the two homologous 
alleles for IgH, Igκ, and TCRβ is marked to rearrange earlier than the other by epigenetic 
marks established early in development, so one allele is predisposed to initiate 
recombination before the other (Mostoslavsky et al., 1998, 2001; Goldmit et al., 2005). 
Additionally, it is possible that initiation of rearrangement is a relatively rare event, so 
that the likelihood of two rearrangements occurring simultaneously in the same cell is 
very low. 
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 The Bassing laboratory showed that in pre-B cells, a third allelic exclusion 
mechanism acts in the time between initial cleavage of one Igκ allele and initiation of 
feedback inhibition by cell surface expression of a complete BCR. Cleavage of Igκ 
activates the DNA damage response protein ATM, which inhibits cleavage of the second 
allele before the first is repaired (Steinel et al., 2013). Importantly, inhibition of V(D)J 
recombination must be transient, as a second recombination event will occur if the first 
is non-productive. 
 ATM deficient mice lacking this transient inhibition of V(D)J recombination have 
an increased frequency of B cells expressing two different Igκ chains on the cell surface, 
a failure of allelic exclusion (Steinel et al., 2013). More recently, we have found that 
ATM deficient mice also have increased allelic inclusion of IgH and TCRβ chains which 
rearrange in pro-B cells and DN thymocytes, respectively. We have further explored the 
genetic and developmental basis of increased TCRβ allelic inclusion in ATM-deficient T 
cells. We find that increased ATM-deficient T cells have a relatively high proportion of 
cells with two rearranged TCRβ alleles, consistent with our hypothesis that the defect in 
allelic exclusion is at the level of rearrangement. Furthermore, we find that this defect is 
already present in pre-selection DP thymocytes. Finally, we examined the effect of 
several molecules proposed to either participate in or cooperate with the ATM-
mediated inhibition signal on Igκ allelic exclusion. We find that the cell cycle regulatory 
protein cyclin D3 has a modest role in promoting Igκ allelic exclusion. The Igκ locus 
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regulatory protein Spi-C was not required for allelic exclusion of the Igκ locus. In 
contrast, Nemo-deficient B cells show a defect in allelic exclusion of approximately the 
same magnitude as ATM-deficient cells. 
Results 
Increased frequency of lymphocytes expressing two IgH or TCRβ chains in ATM-/- mice 
 The importance of ATM-mediated inhibition of V(D)J recombination for Igκ allelic 
exclusion led us to question whether a similar mechanism operates in pro-B and pro-T 
cells, which rearrange IgH and TCRβ genes, respectively. To measure IgH allelic inclusion 
we took advantage of naturally occurring IgM allotypes, IgMA vs. IgMB. We performed 
cell surface staining for these two markers using ATM+/+ IgμA/B and ATM-/- IgμA/B BM cells. 
We found that approximately 0.4% of ATM-/- IgμA/B BM cells expressed both IgMA and 
IgMb, compared to approximately 0.25% of ATM+/+ IgμA/B cells (Fig. 4.1a&b). Although 
these frequencies are low, it is important to note both asynchronous initiation of 
rearrangement and feedback inhibition from a complete antigen receptor are not 
expected to be affected by ATM deficiency, and would both still limit the frequency of 
allelically included cells. We performed similar flow cytometry experiments to measure 
allelic inclusion of the TCRβ chain. Lacking allotypic markers for TCRβ, we conducted this 
analysis using pairs of antibodies that recognize different Vβ segments. Because ATM-/- 
thymocytes exhibit defects in both D-to-J rearrangement and V-to-DJ rearrangement 
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which might limit the frequency of productive biallelic rearrangement, we used Jb1DJ/DJ 
mice in these analyses to limit the opportunity for aberrant recombination events that 
would decrease observed allelic inclusion. In these mice, the TCRβ loci contain a Dβ1-to-
Jβ1 rearrangement encoded in the germline and deletion of Dβ2 and Jβ2, and so only 
undergo V-to-DJ rearrangement of TCRβ (Carpenter et al., 2009). For most Vβ pairs 
tested, we found that ATM-/- Jb1DJ/DJ thymocytes showed a trend towards increased 
double expression, and this difference was significant for several pairs (Fig. 4.1c&d). 
These results support a role for ATM in enforcing allelic exclusion of both IgH and TCRβ.  
Increased allelic inclusion of TCRβ is evident in DP thymocytes 
 As described in Chapter 3, ATM inhibits RAG expression in response to DNA 
damage. This suggests that ATM regulates allelic exclusion at the level of antigen 
receptor gene rearrangement. However, it is also possible that ATM affects selection 
processes that might affect the ability of cells expressing two different IgH or TCRβ 
chains to survive and progress through development (Balomenos et al., 1995). To 
address this issue we measured TCRβ inclusion in earlier stages of T cell development in 
thymocytes from either developing ATM+/+ Jb1DJ/DJ and ATM-/- Jb1DJ/DJ mice. We 
performed surface staining for CD4 and CD8 to divide cells into DN, DP, and SP 
developmental stages. We then performed intracellular staining for pairs of Vβ chains, 
to allow detection of TCRβ chains not yet expressed on the cell surface. As expected, 
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relatively few cells in the DN population expressed Vβ chains. Unfortunately, this fact 
combined with the low frequency of DN thymocytes prevented us from reliably 
detecting dual Vβ expressing cells among either ATM+/+ Jb1DJ/DJ or ATM-/- Jb1DJ/DJ cells 
(Fig. 4.2a). In contrast, dual Vβ expressing cells were easily detected among DP 
thymocytes (Fig. 4.2a). For each Vβ pair tested, ATM-/- Jb1DJ/DJ DP thymocytes had an 
increased frequency of dual expressing cells (Fig. 4.2b). Although we cannot completely 
rule out a role for selection, this result shows that increased allelic exclusion of TCRβ in 
ATM-/- cells is established early in thymocyte development. 
ATM-deficient T cells exhibit increased biallelic rearrangement of TCRβ genes 
 In the case of Igκ allelic exclusion, ATM was shown to promote allelic exclusion 
by inhibiting RAG-mediated cleavage of a second allele before repair of the first cleaved 
Igκ allele. If a similar mechanism operates in pro-B cells rearranging IgH genes and in DN 
thymocytes rearranging TCRβ genes, we would predict that an increased frequency of 
mature lymphocytes would have two completely rearranged IgH or TCRβ genes. We 
used two methods to test this prediction. We used a fluorescence in situ hybridization 
(FISH) assay to measure the frequency of ATM+/+ Jb1DJ/DJ and ATM-/- Jb1DJ/DJ T cells with 
one vs. two V-to-DJ rearrangements of the TCRβ locus. In this assay, we labeled cells 
with two probes; one that hybridizes to the region downstream of the J segments, 
which is present on all intact TCRβ alleles. The second hybridizes between the V 
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segments and the pre-rearranged DJ segment. This probe only hybridizes if the allele has 
not undergone rearrangement. Thus, a VDJ rearrangement is identified by labeling with 
only the downstream probe, while an unrearranged allele is labeled with both probes 
(Fig. 4.3a). Certain aberrant rearrangement events can also be identified in this system; 
for example hybridization of the two probes to different chromosomes indicates a 
translocation event, while hybridization of probe(s) to only one chromosome in a cell 
indicates a large deletion event on one allele. Examples of these scenarios are shown in 
Fig. 4.3b. Notably, small deletion events that might nevertheless affect the productivity 
of a rearrangement are not detected by this method. In the case of perfect allelic 
exclusion, we would predict that 60% of T cells would contain one complete VDJ 
rearrangement. Using this technique, we found that approximately 65% of ATM+/+ 
Jb1DJ/DJ T cells contained only one complete VDJ rearrangement, similar to the 60% 
predicted in the case of perfect allelic exclusion. In contrast, only 53% of ATM-/- Jb1DJ/DJ T 
cells contained one complete V(D)J rearrangement, a significant decrease compared to 
the wild type cells (Fig. 4.3c). We also found an increased frequency of aberrant 
rearrangement events in ATM-/- Jb1DJ/DJ T cells (Fig. 4.3d). 
 The FISH analysis cannot address the question of whether any of the cells with 
two complete rearrangements contain two productive rearrangements. To address this 
question, we generated a panel of T cell hybridomas from ATM-/- Jb1DJ/DJ spleen cells and 
analyzed the rearrangement status of their TCRβ loci by Southern as previously 
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described (Khor and Sleckman, 2005). We obtained a total of 171 clones in this analysis; 
38 were rejected from the analysis because only a single TCRβ band could be detected 
by southern. This might be caused by loss of an allele during hybridoma fusion or 
aberrant rearrangement, both of which might be affected by ATM deficiency. Of the 
remaining 133 clones, 87 (65.4%) contained only one complete VDJ rearrangement (Fig. 
4.3e). We further analyzed the 46 hybridoma lines containing two complete 
rearrangements to determine if any of these contained two productive rearrangements. 
We first identified the Vβ segments involved in rearrangement by a PCR screen, and 
then sequenced the PCR products obtained. Four lines were excluded at this step 
because we were unable to obtain two sequences. Of the remaining 42 clones, 3 (7.1%) 
contained two productive rearrangements (Fig. 4.3f). A older study examining wild-type 
hybridomas detected no examples of T cell hybridomas with two productive 
rearrangement (Khor and Sleckman, 2005). The frequency of ATM-/- Jb1DJ/DJ containing 
two VDJ rearrangements (65.4%) is similar to the amount predicted in the case of 
perfect allelic exclusion, but the presence of 3 lines containing two productive 
rearrangements indicates a defect in allelic exclusion.  
Cyclin D3 deficiency leads to a minor defect in allelic exclusion of Igκ 
 Having established the importance of ATM for allelic exclusion of IgH, TCRβ, and 
Igκ loci, we wanted to identify other factors that either participate in the ATM-mediated 
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regulation of allelic exclusion or complement ATM's activity. Work by Natalie Steinel in 
the Bassing lab showed that the cell cycle regulatory protein cyclin D3 helps enforce 
allelic exclusion of the IgH and TCRβ loci, and that double deficiency of ATM and cyclin 
D3 have an additive effect on allelic inclusion (Steinel et al., 2014). Normally, cyclin D3 
promotes the proliferative expansion that occurs upon expression of a pre-BCR or pre-
TCR, as developing lymphocytes transition from the pro- to pre-B or T cell stage (Sicinska 
et al., 2003; Cooper et al., 2006). As this proliferation is believed to play a part in both 
RAG downregulation and chromatin alterations of IgH and TCRβ loci, it was suggested 
that cyclin D3 deficiency increases allelic inclusion in ATM+/+ or ATM-/- lymphocytes by 
increasing the time available for a second recombination event after the first is 
completed. However, cyclin D3 was also shown to repress germline VH transcription in 
pro-B cells, indicating that it may also promote allelic exclusion by directly suppressing 
accessibility of antigen receptor loci to the RAG recombinase (Powers et al., 2012). As 
pre-B cells do not undergo a proliferative burst following expression of the BCR, cyclin 
D3's role in promoting proliferation would not be expected to affect Igκ allelic exclusion 
in pre-B cells. However, if cyclin D3 has a role in directly regulating Igκ accessibility, it 
might impact Igκ allelic exclusion in this way. To test the role of cyclin D3 in Igκ allelic 
exclusion, we used the mice in which one Igκ constant region allele was replaced with 
the equivalent human gene (Igκh), while the other allele was wild type (Igκm) allowing 
the two Igκ alleles to be stained by two different antibodies (Casellas, 2001). We found 
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that the frequency of cells expressing Igκm and Igκh together was slightly higher in  
Ccnd3-/- Igκh/m BM cells than in Ccnd3+/+ Igκh/m BM cells, approximately 2.25 % compared 
to 1.9% (Fig. 4.4a&b). Among splenic B cells, no significant increase in Igκ biallelic 
expression was found in Ccnd3-/- Igκh/m cells (Fig. 4.4 a&b). This very small increase in Igκ 
allelic inclusion, which does not persist in the periphery, is far less than the 
approximately 2-fold increase in IgH allelic inclusion found in Ccnd3-/- B cells. Therefore, 
cyclin D3 appears to play at most a minor role in promoting Igκ allelic exclusion. 
Spic deficiency does not affect allelic exclusion of Igκ 
 It has been proposed that DSBs regulate accessibility of the Igκ locus in addition 
to suppressing Rag1 and Rag2 expression. In this context, RAG mediated DSBs have 
been shown to act through ATM to increase expression of the Ets family protein Spi-C 
(Bednarski et al., 2016). Spi-C lacks the ability to activate transcription, and has been 
shown to inhibit the activity of transcriptionally activate Ets family members by 
competing for binding (Hashimoto et al., 1999; Schweitzer et al., 2006). In the context of 
RAG-mediated DSBs, Spi-C overexpression was shown to partially inhibit Igκ cleavage in 
ATM-/- pre-B cells that would otherwise experience no inhibition of Igκ cleavage 
(Bednarski et al., 2016). In light of these findings, we hypothesized that increased Spi-C 
expression may decrease accessibility of the Igκ locus and cooperate with the 
suppression of Rag1 and Rag2 expression to promote allelic exclusion. Indeed, in the Igκ 
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cleavage assays discussed in Chapter 2 (Fig. 2.5a), the accumulation of cleaved Igκ alleles 
that occurs upon treatment of Artemis-/- cells with sti571 is accompanied by increased 
Spic mRNA expression; addition of the DNA damaging agent etoposide might cause a 
slight additional increase (Fig. 4.5a). To determine whether Spi-C expression is necessary 
to enforce allelic exclusion of the Igκ locus, we performed flow cytometry on Spic+/+ 
Igκh/m and Spic-/- Igκh/m BM cells and splenocytes. We observed approximately normal 
frequencies of pre-B cells in Spic-/- Igκh/m BM cells, although they express to have slightly 
increased levels of CD43 expression, and slightly decreased levels of B220 (Fig. 4.5b); 
this might be due to defects in regulating pre-B cell-specific gene expression. 
Nevertheless, we found no defect in Igκ allelic exclusion in the BM, and actually found a 
slight decrease (approximately 20%) in allelic inclusion among Spic-/- Igκh/m splenocytes 
(Fig. 4.5c). These results show that Spi-C expression is not necessary for normal Igκ 
allelic exclusion. 
Nemo deficiency causes an increase in Igκ allelic inclusion 
 In Chapter 3 we described a role for Nemo in mediating suppression of Rag1 and 
Rag2 expression. As Nemo is a known target of ATM activity, we propose that Nemo 
acts downstream of ATM to mediated suppression. As discussed above, developing 
lymphocytes that lack this pathway due to ATM-deficiency exhibit increased allelic 
inclusion of IgH, TCRβ, and Igκ (Fig. 4.1 and Steinel et al., 2013). To determine if Nemo-
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deficiency has a similar effect on allelic inclusion of Igκ, we performed flow cytometry 
on Nemo+/+ Igκh/m and Nemo-/- Igκh/m BM cells and splenocytes. In accordance with the 
known survival defect of mature Nemo-/- B cells, we found relatively few of the most 
mature B220high cells in Nemo-/- Igκh/m BM (Fig. 4.6a and Sasaki et al., 2006). As we have 
previously observed that these mature cells tend to exhibit the highest levels of allelic 
inclusion, we analyzed Igκh and Igκm expression both in total B220+ CD43- cells (Fig. 4.6a, 
red box), and in the less mature B220intermediate CD43- population (Fig. 4.6b, blue box). In 
both cases we found an approximately 50% increase of Igκh/Igκm dual expressing cells 
among Nemo-/- Igκh/m BM cells compared to Nemo+/+ Igκh/m (Fig. 4.6b). We found a 
similar 50% increase in allelic inclusion in Nemo-/- Igκh/m splenocytes. In contrast, Atm-/- 
Igκh/m BM cells and splenocytes exhibit an approximately 2-fold increase in Igκ allelic 
inclusion (Steinel et al., 2013). These results are consistent with the mechanistic data 
presented in Chapter 3, where we show that ATM is absolutely required for suppression 
of Rag1 and Rag2 expression in response to DSBs, while Nemo is only partially 
responsible for this suppression. Together, these data are consistent with a role for 
Nemo in enforcing allelic exclusion, likely as one downstream effecter of ATM activity. 
Discussion 
 Steinel et al. originally proposed that ATM regulates allelic exclusion through its 
role in inhibiting Rag1 and Rag2 expression in response to a RAG-mediated DSB (Steinel 
et al., 2013). Here, we demonstrate several parallels between the regulation of allelic 
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exclusion and the regulation of Rag1 and Rag2 expression by DSBs. First, we find that 
DSBs suppress Rag1 and Rag2 expression in pro-B and pre-B cells and in DN thymocytes, 
the cell subsets that rearrange the allelically excluded antigen receptor chains IgH, Igκ, 
and TCRβ. Conversely, pre-T cells rearranging the non-allelically excluded TCRα chain do 
not suppress Rag1 and Rag2 expression in response to DSBs. This finding suggests 
suppression of Rag1 and Rag2 expression by DSBs is common mechanism for enforcing 
allelic exclusion, similar to the common role of inhibition from cell surface antigen 
receptors and asynchronous initiation of recombination (Mostoslavsky et al., 2004). 
Furthermore, we find that ATM is important for promoting allelic exclusion of IgH and 
TCRβ, consistent with a role for DSB-mediated suppression of Rag1 and Rag2 expression 
in promoting allelic expression in pro-B cells and DN thymocytes. Finally, we find that 
the NF-κB regulatory protein Nemo plays a role in both regulation of Rag1 and Rag2 
expression by DSBs and in allelic exclusion. Collectively, these results provide strong 
support for the hypothesis that feedback inhibition by RAG-mediated DSBs plays an 
important role in promoting allelic exclusion.  
 Notably, the inability of constitutive Rag1 expression to restore V(D)J 
recombination activity in pre-B cells experiencing etoposide-induced DSBs (Fig. 2.6e) 
suggests that the inhibitory signal may involve more than simply suppression of Rag1 
and Rag2 transcription. Additional factors might involve post-translational modification 
of Rag1 and/or Rag2 proteins or decreased accessibility of antigen receptor loci. 
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Additional experiments will be necessary to determine the relative importance of Rag1 
and Rag2 mRNA suppression and alternative mechanisms in promoting allelic exclusion. 
 We did not find a role for Spi-C in enforcing Igκ allelic exclusion, despite the 
published finding that Spi-C expression is induced by RAG-mediated cleavage of Igκ and 
can suppress Igκ cleavage in the absence of ATM activity (Bednarski et al., 2016). The 
published data shows Spi-C induction and activity over the course of days; it is possible 
that Spi-C induction is irrelevant in the much shorter timeframe of normal V(D)J 
recombination cleavage and repair. Indeed, we see induction of Spic mRNA expression 
when measuring Igκ cleavage in a pre-B cell line over the course of three days; however 
we do not see any induction within four hours of exposing primary pre-B cells to IR or 
etoposide (Fig. 4.5a and data not shown). Furthermore, the effect of Spi-C on Igκ 
cleavage was only shown in ATM-deficient cells; it is possible that it is relatively 
unimportant in the presence of normal ATM activity. In this respect, it is possible Spi-C 
induction complements the function of other factors acting downstream of ATM, such 
as suppression of Rag1 and Rag2 expression. Additional experiments will be necessary 
explore the possibility that Spi-C induction and suppression of Rag1 and Rag2 
expression act synergistically to inhibit V(D)J recombination and promote allelic 
exclusion. 
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Figure 4.1 
 
Figure 4.1: Increased allelic inclusion of IgH and TCRβ in ATM-deficient mice. (A) 
Representative flow cytometry analysis showing cell surface expression of allotypically 
marked IgM proteins in Atm+/+Jb1DJ/DJ or AtmJb1DJ/DJ mice B220+ BM cells. (B) 
Representative flow cytometry analysis showing cell surface expression of Vβ8 and Vβ14 
among Atm+/+Jb1DJ/DJ or AtmJb1DJ/DJ mice TCRβ+ thymocytes. (C) Quantification of 
dual IgM expressing B cells as shown in (A). (D) Quantification of thymocytes with dual 
expression of the indicated Vβ pairs as shown in (B). p values determined by t-test. Error 
bars indicate SEM. 
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Figure 4.2 
 
Figure 4.2: Increased allelic inclusion in ATM-deficient thymocytes is established by the 
DP stage of development. (A) Representative flow cytometry analysis of intracellular 
expression of Vβ14 and Vβ8 expression in DN or DP thymocytes isolated from 
Atm+/+Jb1DJ/DJ or Atm−/−Jb1DJ/DJ mice. The circle gates indicate where cells expressing 
equivalent high levels of both Vβ14 and Vβ8 should be visualized. DN thymocytes lacked 
detectable populations of Vβ14+Vβ8+ cells, whereas DP thymocytes contained 
populations that comprised the indicated percentage of DP cells. (B) Quantification of 
the average frequencies of DP thymocytes that express each indicated combination of 
Vβ chains in their cytoplasm as depicted in (A). Data are from two independent 
experiments conducted on a total of seven Atm+/+Jb1DJ/DJ and eight Atm−/−Jb1DJ/DJ 
littermate mice. Error bars indicate SEM.  
110 
 
Figure 4.3 
 
Figure 4.3: ATM-deficient T cells include a high frequency of cells with two TCRβ VDJ 
rearrangements. (A) Schematic of the TCRβ locus including with pre-rearranged Jb1DJ/DJ 
allele. Red and green lines indicate areas of probe hybridization for FISH analysis. (B) 
Examples of cells containing 2 rearranged TCRβ alleles (VDJ/VDJ), 1 rearranged allele 
and 1 unrearranged allele (VDJ/DJ), or 1 rearranged allele and a deletion of the second 
allele (VDJ/Ø). (C) Frequency of Atm+/+Jb1DJ/DJ or Atm-/-Jb1DJ/DJ spleen cells with one vs. 
two rearranged TCRβ alleles, as measured by FISH. p value calculated by chi-square test. 
(D) Frequency of aberrant rearrangement events (deletions, translocations, 
duplications) in Atm+/+Jb1DJ/DJ vs. Atm-/-Jb1DJ/DJ spleen cells containing at least one TCRβ 
rearrangement, as measured by FISH. p value calculated by chi-square test. (E) 
Frequency of cells with one vs. two TCRβ rearrangements as determined by Southern 
analysis of ATM-/- Jb1DJ/DJ T cell hybridoma lines. (F) Frequency of cells with one vs. two 
productive TCRβ rearrangements as determined by PCR and Sanger sequencing of TCRβ 
rearrangements from ATM-/- Jb1DJ/DJ T cell hybridoma lines. 
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Figure 4.4 
 
Figure 4.4: Ccnd3-/- B cells exhibit a modest increase in Igκ allelic inclusion. (A) 
Representative FACS plots showing Igκh and Igκm expression in Ccnd3+/+ Igκh/m and 
Ccnd3-/- Igκh/m BM and spleen cells. The gate represents cells expressing equivalently 
high levels of both Igκh and Igκm. (B) Quantification of B220+ CD43- Ccnd3+/+ Igκh/m and 
Ccnd3-/- Igκh/m BM and spleen cells expressing both Igκh and Igκm as depicted in (A). p-
values determined by t-test. Error bars represent SEM. 
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Figure 4.5 
 
Figure 4.5: Spic-/- B cells exhibit normal Igκ allelic inclusion. (A) Spic mRNA expression in 
Artemis-/- Abelson pre-B cells exposed to sti571 alone or sti571 and etoposide for the 
indicated times. (B) Representative FACS plots showing Igκh and Igκm expression in 
Spic+/+ Igκh/m and Spic-/- Igκh/m BM and spleen cells. The gate represents cells expressing 
equivalently high levels of both Igκh and Igκm. (C) Quantification of B220+ CD43- Spic+/+ 
Igκh/m and Spic-/- Igκh/m BM and spleen cells expressing both Igκh and Igκm as depicted in 
(B). p-values determined by t-test. Error bars represent SEM. 
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Figure 4.6 
 
Figure 4.6: Nemo/- B cells exhibit increased in Igκ allelic inclusion. (A) Representative 
FACS plots showing Igκh and Igκm expression in Nemo+/+ Igκh/m and Nemo-/- Igκh/m BM and 
spleen cells. The gate represents cells expressing equivalently high levels of both Igκh 
and Igκm. (B) Quantification of B220+ CD43- cells or B220intermediate CD3- Nemo+/+ Igκh/m 
and Nemo-/- Igκh/m BM and spleen cells expressing both Igκh and Igκm as depicted in (A). 
p-values calculated by t-test. Error bars represent SEM. 
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Chapter 5: Discussion 
 V(D)J recombination is crucial for lymphocyte development and immune 
function, but poses risks at multiple levels. Deliberate cleavage and rearrangement of 
DNA could lead to genomic instability and malignant transformation (Schlissel, 2006). 
The largely random nature of the final product necessitates stringent selection 
processes to promote the development of cells with useful receptors and eliminate 
those with potentially harmful ones (Pelanda and Torres, 2012; Xing and Hogquist, 
2012). In light of these hazards, it has long been recognized that lymphocytes carefully 
regulate V(D)J recombination in many respects. Most obviously, V(D)J recombination is 
strictly limited to developing lymphocytes, and specific rearrangement events are 
restricted to certain developmental windows. Within those windows, it is generally 
found that only one antigen receptor gene rearranges at a time (Hewitt et al., 2009; 
Chan et al., 2013; Chaumeil et al., 2013). This asynchronous recombination, combined 
with feedback signals generated by newly synthesized antigen receptors, leads to allelic 
exclusion of several antigen receptors (Brady et al., 2010). In this work, we describe a 
signal originating from DNA double strand breaks, which activates a conserved DNA 
damage response pathway involving ATM and Nemo. We build on previous work from 
the Bassing laboratory to show that this pathway helps to promote allelic exclusion in 
developing B and T cells. 
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Regulation of Rag1 and Rag2 expression 
 The regulation of Rag1 and Rag2 expression has mostly been studied in 
relationship to developmental signals. Most notably, many factors that turn on Rag1 
and Rag2 expression at appropriate stages of T and particularly B cell development have 
been identified. The previously identified suppressive signals originate from cell-surface 
antigen receptors, which have long been known to turn off Rag1 and Rag2 expression 
(Li et al., 1993; Turka et al., 1991). The work presented in this dissertation shows that a 
very different kind of stimulus, DNA damage, can also turn off Rag1 and Rag2 
expression. We also find that LPS stimulation suppresses Rag1 and Rag2 expression in 
pre-B cells. These findings suggest that Rag1 and Rag2 expression is subject to more 
complex regulation than has generally been considered. Additional work will be 
necessary to determine how these signals affect lymphocyte development in vivo. 
 A model of our findings and open questions regarding the mechanism by which 
RAG-mediated or exogenous DSBs suppress V(D)J recombination is depicted in Fig. 5.1. 
To summarize, we have shown that DSBs activate ATM, which is required for 
transcriptional suppression of Rag1 and Rag2. Loss of Rag1 and Rag2 transcripts is 
accompanied by loss of Rag1 protein. Lack of the complete RAG recombinase prevents 
cleavage of antigen receptor loci. However, the inability of Rag1 reconstitution alone to 
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promote Igκ cleavage in the presence of DSBs (Fig. 2.6) suggests that additional signals 
may act in parallel to suppress V(D)J recombination in the presence of DSBs.  
 The role of NF-κB factors in regulating Rag1 and Rag2 expression will be of 
particular interest. As discussed in Chapter 3, the literature on this subject and our own 
work present several apparent contradictions. Ambiguity in precisely which NF-κB 
factors are manipulated in different studies may account for some of this confusion. Our 
own work shows that two different IKKβ inhibitors have different effects on Rag1 and 
Rag2 expression. The more specific inhibitor leads to a slight increase in Rag1 and Rag2 
expression in pre-B cells and partially prevents suppression upon IR exposure. Another 
inhibitor that affects IKKα as well as IKKβ leads to a slight decrease in Rag1 expression 
and a substantial decrease in Rag2 expression, which makes the effect of IR difficult to 
interpret. These results suggest that both IKKs have a modest basal effect on Rag1 and 
Rag2 expression, and that these effects oppose each other. 
 Another possibility is that the effect of NF-κB signaling may change during the 
course of development. Expression of many NF-κB factors changes as cells approach 
maturity (Sup. Fig. 3.4 and Kistler et al., 1998); a change in the relative expression in 
different factors might change the target genes they bind to and their activating or 
inhibitory effects on transcription of those genes. One study to date that shows an 
inhibitory effect of NF-κB signaling on Rag1 and Rag2 expression dealt with expression 
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in immature B cells (Verkoczy et al., 2005). It is possible that NF-kB signaling earlier in 
development could have different effects. It is also possible that different stimuli that 
activate NF-κB might simultaneously activate other signaling pathways that interact with 
and modify NF-κB signals. 
Potential role for parallel signals in suppressing V(D)J recombination 
 The failure of constitutive Rag1 mRNA expression to restore V(D)J recombination 
activity in the presence of etoposide suggests that additional signals beyond 
suppression of Rag1 expression are involved. Given the demonstrated involvement of 
ATM, direct phosphorylation of Rag1 or Rag2 proteins may occur. Inactivation by 
phosphorylation could have the advantage of acting more rapidly than transcriptional 
suppression of Rag1 and Rag2, as it takes some time to deplete the Rag1 protein pool 
by degradation. Both proteins contain motifs that could be targeted by ATM or DN-PKcs, 
a related kinase that is also activated by RAG-mediated DSBs (Gapud et al., 2011).  
 Phosphorylation by other kinases might also play a role. One study 
demonstrated that some Rag2 protein is exported from the nucleus following IR, and 
that export requires the cdk-phosphorylation site T490 (Rodgers et al., 2015). Regulated 
degradation of Rag2 at the G1/S checkpoint also depends on phosphorylation of T490 
(Jiang et al., 2005). However given that neither we nor the Rodgers group observe 
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degradation of Rag2 protein upon IR, T490 phosphorylation may play another role in 
this circumstance. 
 Another potential method of suppressing RAG activity is to decrease the 
accessibility of target antigen receptor loci. In this regard, we looked for a role for the 
Ets-family member Spi-C, which was recently shown to decrease Igκ locus accessibility, 
presumably by competing with transcriptionally active Ets family (Bednarski et al., 
2016). Although we confirmed the finding that Spi-C is induced in cells accumulating 
RAG-mediated DSBs, we did not find a role for this protein in allelic exclusion. It is 
possible that it plays a secondary role, perhaps complementing the effect of suppression 
of Rag1 and Rag2 expression. As-yet unidentified factors acting at antigen receptor loci 
may also play a role. 
Allelic exclusion and genomic stability 
 The results presented in Chapter 4 and previously published studies suggest that 
ATM suppresses allelic inclusion by promoting monoallelic rearrangement of antigen 
receptor alleles (Chaumeil et al., 2013; Steinel et al., 2013). Monoallelic rearrangement 
may also be important for genomic stability of developing lymphocytes, as formation of 
a productive rearrangement that leads to developmental progression could lead to 
aberrant rearrangement of a second allele that remains unrepaired. The proliferative 
burst that occurs after the pro-B cell or DN thymocyte stages may pose a particular 
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hazard in this regard, which may be one reason that allelic exclusion is enforced more 
strictly for the IgH and TCRβ chains than for Igκ and TCRα (Brady et al., 2010).  
Allelic exclusion and autoimmunity 
 Although allelic exclusion of antigen receptors was first described over fifty years 
ago, its importance is still debated. A long-standing hypothesis posits that allelic 
exclusion is required for proper positive and negative selection of developing 
lymphocytes (Vettermann and Schlissel, 2010). Central tolerance mechanisms that cull 
self-reactive B and T cells depend stimulation of those cells through their cell surface 
receptors. In an allelically included cell, the cell-surface concentration of an autoreactive 
receptor might be diluted by a 
+ second innocuous receptor so that it does not trigger central tolerance mechanisms 
that would normally lead to removal of the autoreactive receptor from the repertoire. 
However, if the cell later became activated through the innocuous receptor, the activity 
of the self-reactive receptor might lead to autoimmune disease (Vettermann and 
Schlissel, 2010).  
 Experimental evidence regarding this idea has been mixed. Several groups have 
shown that cells engineered to express antigen receptor chains likely to mediate self-
reactivity have shown that co-expression of an endogenous receptor can indeed allow 
development of cells carrying self-reactive receptors; however in most cases resulting 
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autoimmune disease was not reported, perhaps because peripheral tolerance 
mechanisms provided sufficient protection (Iliev et al., 1994; Zal et al., 1996; Gerdes and 
Wabl, 2004). In contrast, one study employing transgenic expression of both TCR and 
the cognate antigen found that co-expression of an endogenous TCRα chain could allow 
T cells to evade tolerance mechanisms and cause diabetes (Sarukhan et al., 1998). A 
limitation of all these studies is the extreme overrepresentation of a single self-reactive 
receptor, a situation that is not representative of a normal immune system. One study 
instead used transgenic expression of an Igκ chain that was not expected to be 
particularly self-reactive; this led to a relatively high frequency of Igκ/λ inclusion, but not 
to noticeably high levels of autoantibody production or autoimmune disease (Sirac et 
al., 2006). Finally, several groups have examined the self-reactivity of naturally occurring 
allelically included cells; conflicting results have come from these studies. In studies of 
lupus prone mice, one group found that cells expressing two Igκ chains were more likely 
than single-expressers to produce autoantibodies, while another group using a different 
lupus model found the opposite (Fournier et al., 2012; Makdasi and Eilat, 2013). The use 
of two different models suggest that strain differences may account for this 
contradiction. It is possible that lapses in other tolerance mechanisms would be 
necessary to reveal any increased autoreactive potential possessed by allelically 
included lymphocytes. 
 
121 
 
Steps toward a new model of allelic inclusion 
 A tool that has been lacking in this field is a model of increased allelic inclusion in 
the absence of other immune system abnormalities. Antigen receptor transgenic models 
skew the immune repertoire unnaturally. Unfortunately, although deficiency of either 
ATM or Nemo increases allelic inclusion, these mice are also not ideal models. ATM 
deficient mice are somewhat lymphopenic, have impaired specific antibody production, 
and develop lymphoma by four months of age, all of which confound investigations into 
of the effects of allelic inclusion on the immune system (Xu et al., 1996). Nemo-deficient 
B cells develop fairly normally but do not die upon reaching maturity (Sasaki et al., 
2006). It is our hope that further elucidation of the signaling events leading to the 
suppression of RAG expression and V(D)J recombination will allow a more targeted 
disruption of the signal in vivo, increasing allelic inclusion without impairing critical 
immune functions.  
 A first, relatively blunt approach will be to constitutively express Rag1. 
Constitutive expression of both Rag1 and Rag2 was previously reported; in this case a 
decrease in allelic exclusion was reported, but this might be due to the severe 
impairment of B and T cell development reported in these mice (Barreto et al., 2001). It 
was surmised that impaired development was due to RAG activity during inappropriate 
developmental stages; by constitutively expressing only Rag1 we hope to avoid this 
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problem. Our finding that Rag2 protein persists in the presence of DSBs due to its long 
half-life suggests that maintaining expression of Rag1 alone will be sufficient to 
overcome the transient suppressive signal activated by a RAG-mediated DSB and 
promote allelic inclusion. However, a more thorough understanding how Rag1 and Rag2 
transcription is suppressed by DSBs might allow us to take a more nuanced approach to 
disrupting this signal. For example, if we identify a suppressive factor that turns off 
Rag1/Rag2 transcription, it may be possible to mutate its binding site to specifically 
prevent suppression of Rag1 and Rag2 expression. 
V(D)J recombination and genomic stability 
 In addition to promoting allelic exclusion, we propose that suppression of Rag 
expression and V(D)J recombination serves to limit the probability of antigen receptor 
translocation. When antigen receptor loci are involved in translocations, they can drive 
the expression of proto-oncogenes and promote malignant transformation (Schlissel, 
2006). A translocation necessarily requires DNA breaks at two genomic locations. 
Accordingly, it has been formally shown that increasing the frequency of DSBs at a locus 
increases the frequency of translocation (Richardson and Jasin, 2000). Therefore, 
cleavage of an antigen receptor locus in the presence of a pre-existing DSB is likely to be 
particularly risky. The models proposed above to study allelic exclusion will also be 
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helpful in testing the hypothesis that suppression of Rag1 and Rag2 expression by DSBs 
helps to prevent oncogenic antigen receptor translocations. 
Concluding remarks 
 The work presented in this dissertation shows how developing lymphocytes use 
the conserved DNA damage response to address lymphocyte-specific developmental 
needs. These data add to our understanding of Rag expression and its role in allelic 
exclusion. The ability of DSBs to regulate Rag1 and Rag2 expression in both developing 
B and T cells, which otherwise regulate Rag1/Rag2 using largely distinct mechanisms, 
suggests that this signal plays an important role in lymphocyte biology. 
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Figure 5.1 
 
Figure 5.1: Model of inhibition of V(D)J recombination by DSBs. Left panel shows a 
normal situation in which Rag1 and Rag2 are transcribed and produce protein, leading 
to RAG-mediated cleavage of an antigen receptor locus. Right panel shows DSB signaling 
to suppress V(D)J recombination. Black, solid lines represent signals described in this 
dissertation. Gray, dotted lines represent hypothetical signals that might cooperate with 
loss of Rag1 and Rag2 transcription and Rag1 protein in suppressing V(D)J 
recombination. 
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Methods 
Mice 
All mice used within this study were housed, bred, and used under pathogen-free 
conditions at the Children's Hospital of Philadelphia (CHOP). All experiments were 
performed using 4-6 week old mice using both male and female mice. Experimental 
mice were euthanized by exposure to CO2 followed by cervical dislocation. Animal 
husbandry and experiments were performed in accordance with national guidelines and 
regulations and approved by the CHOP Institutional Animal Care and Use Committee. 
The EμBCL2 (Strasser et al., 1991b) Atm-/- , Mb1Cre+Atmflox/flox(Steinel et al., 2013), 
VavCre+p53flox/flox (DeMicco et al., 2013), Mb1Cre+Nemoflox/flox (Derudder et al., 2009) 
mice were on a mixed 129S1/SvImJ and C57BL/6 background, while Rag1-/- (Mombaerts 
et al., 1992a) and Rag2-/- (Hao and Rajewsky, 2001) mice were on the C57BL/6 
background.  
Irradiation 
All mice were subject to irradiation using an XRAD320 X-ray irradiator (Precision X-Ray) 
and a dose rate of 0.74 Gy/min. Primary cells and cell lines were subject to irradiation 
using a Gammacell 1000 Cs-137 irradiator (Nordion Inc) and a dose rate of 1.8 Gy/min.  
 
126 
 
qRT-PCR quantification of Rag1, Rag2, and p21 mRNAs 
Non-irradiated and irradiated cells were harvested at indicated time points and 
immediately lysed in Trizol (Life Technologies) and processed according to the 
manufacturer's instructions. Isolated RNA was treated with DNase (Promega) according 
to manufacturer directions, primed with random nonamers (New England Biolabs, NEB), 
and reverse transcribed with M-MuLV (NEB) to generate cDNA. The cDNAs were then 
used as template for qRT-PCR reactions were performed with SYBR green mastermix 
(Applied Biosystems) and run on an Applied Biosystems 7500 Fast machine. Values were 
normalized to housekeeping genes as indicated in the text and fold change was 
determined by the ΔΔCT method. The primers used for qRT-PCR reactions are listed in 
Table 1. When pre-B cells were subject to irradiation, non-irradiated pre-B cells also 
were transported to the irradiator, but not exposed to ionizing radiation along with 
irradiated samples. The irradiated and non-irradiated pre-B cells were each placed back 
into culture until they were harvested. Since pre-B cells were transported to and from 
the irradiator at room temperature, the basal levels of Rag1, Rag2, and p21 mRNAs 
were lower at 1 hour after the irradiation time point than at 4 hours after the irradiation 
time point.  
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Small molecule inhibitors 
To inactivate the ATM kinase, the KU55933 ATM kinase inhibitor was added to media at 
a concentration of 15 μM. To block new protein synthesis, the ribosome inhibitor 
cycloheximide was added to media at a concentration of 10 μg/mL. To block protein 
degradation, the proteosome inhibitor MG132 was added to media at a concentration 
of 10 μM. To inhibit IKKβ either 5μM BMS-345541 or 20μM ML120B was used. To 
induce DSBs by genotoxic drugs, etoposide was added to the media at a concentration 
of 10 μg/mL or bleomycin was added at a concentration of 5 μM. 
Primary pre-B cell cultures 
Primary bone marrow (BM) cells were harvested by flushing BM from all leg bones of at 
least four mice of the appropriate genotype for each experiment. These BM cells were 
cultured for 3-5 days in RPMI supplemented with 10% FBS, 10 mM HEPES, 1 x non-
essential amino acids, 1 mM L-glutamine, 1 mM sodium pyruvate, 100 U/mL pen-strep, 
30 μM β-mercaptoethanol and 50 ng/mL IL-7. Cells were plated at a density of 5 million 
cells per mL of media. Each day, cells were harvested and put back into culture in fresh 
media at a density of 5 million cells per mL. To induce G1 arrest and activate 
transcription of Rag1 and Rag2 by IL7 withdrawal, cells were pelleted by centrifugation, 
re-suspended in the same media lacking IL7 at a density of 5 million cells per mL, and 
treated as described for each experiment.  
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Western blots  
Pre-B cells were washed with PBS and re-suspended in ice cold lysis buffer (20 mM Tris 
pH 7.4, 20 mM glycerol phosphate, 10 mM sodium orthovanadatem, 10% glycerol, 0.5 
mM EDTA, 0.5 mM MgCl2, 200 mM NaCl, and 0.2% Triton-X) and then sonicated at 
intervals of 30 seconds on and 30 seconds off for 8 minutes at 4°C. The sonicated cells 
were incubated on ice for 10 minutes and then centrifuged to remove insoluble 
material. Laemmli buffer was added and then samples were boiled for 5 minutes. 
Lysates from equivalent numbers of pre-B cells were loaded and run on NuPage tris-
glycine gels (Life Technologies). Electrophoresed proteins were transferred to 
Immobilon-FL PVDF membrane (EMD Millipore). Membranes were blocked with 
Odyssey blocking buffer (Li-Cor) according to manufacturer’s instructions. Antibodies 
used are: anti-Rag1 or anti-Rag2 monoclonal antibody (Coster et al., 2012); anti-actin 
antibody (Sigma AV40173); anti-Gadd45α (Santa Cruz sc-797); anti-phospho IKKα/IKKα 
(Cell Signaling Technology 2697S); anti-IKKα/IKKα (Santa Cruz sc-7607). Blots were 
washed and incubated with appropriate IRDye800 secondary antibodies (LiCor) 
according to manufacturer’s instructions. After washing, blots were scanned on an 
Odyssey infrared scanner (Li-Cor).  
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Click-It analysis of Rag1 and Rag2 mRNA turnover and Rag1 and Rag2 transcription 
These assays were conducting using Click-It® Nascent RNA Capture kits (Life 
Technologies). For mRNA turnover assays, ethynyl uridine (EU) was added to medium of 
IL7 withdrawn pre-B cell cultures at a final concentration of 0.2 mM for the final 16 
hours of culture time. Pre-B cells were washed, placed into media lacking EU, and then 
split into pools that were immediately irradiated or left non-irradiated. Cell pools were 
collected for RNA isolation immediately before EU removal or at indicated times after 
EU removal or EU removal and irradiation. For transcriptional assays, pre-B cells were 
grown in media lacking EU. Cultures were split into pools that were either irradiated or 
left non-irradiated. Immediately after irradiation of some pools, EU was added to the 
media of all pools at a final concentration of 0.5 mM. After the indicated times, cells 
were collected for RNA isolation. For both assays, RNA was isolated using Trizol (Life 
Technologies) according to the manufacturer's instructions. Click chemistry and 
streptavidin pull down of EU-labeled RNA were performed according to the Click-It 
Nascent RNA Capture kit’s instructions. Pulled-down RNA was reverse transcribed and 
analyzed by qRT-PCR as described above. The loading controls for mRNA turnover and 
transcription experiments were 18S RNA and Hprt mRNA, respectively. 
 
 
130 
 
Abelson pro-B cell cultures 
The EμBCL2 (A2) and Artemis-/-EμBCL2 (Art2.1) Abelson transformed and immortalized 
pro-B cell lines were previously described (Bredemeyer et al., 2006; Savic et al., 2009). 
We made the EμBCL2-pINV Abelson pro-B cell line using the same procedures that we 
previously used to generate cell lines with recombination substrates (Gapud et al., 
2011). Abelsons pro-B cells were cultured in RPMI media supplemented with 10% FBS, 
100 U/mL pen-strep, and 30 μM μ-mercaptoethanol To induce G1 cell cycle arrest, 
differentiation into pre-B cells, expression of Rag1 and Rag2 mRNA, and V(D)J 
recombination, 5 μM STI571 was added to the culture media.  
Southern blot analysis of Jκ cleavage 
Southern blotting was performed as described (Savic et al., 2009). Briefly, 15-20 μg of 
genomic DNA was digested with Sac1-HF (NEB) and EcoR1-HF (NEB). Southern blot 
membranes were probed with a 3’Jκ probe and then a 5'Hprt probe as a loading control. 
The intensities of bands were quantified using ImageJ software (NIH). For Artemis-/-
EμBLC2 cells, the percentage of Jκ cleavage at each time point was calculated by dividing 
the total intensities of Jκ coding end bands by the combined intensities of the germline 
Jκ band and Jκ coding end bands (Yin et al., 2009). For EμBLC2 cells, the percentage of Jκ 
cleavage at each time point was calculated by dividing the intensity of the germline Jκ 
band by the intensity of the 5'Hprt control band. 
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Flow cytometry for pMX-INV rearrangement 
For analysis of GFP expression in EμBCL2-pINV cells, cells were washed in FACS buffer 
(PBS with 3% FCS and 0.25 mM EDTA) and then stained with PE-conjugated anti-human 
CD4 antibody (BD Pharmigen, clone RPA-T4) to stain cells containing the substrate. Flow 
cytometry was conducted using an LSR-II flow cytometer (BD Biosciences) and data was 
analyzed using FlowJo 10.  
Flow cytometry for IgM allelic inclusion 
Stains were conducted using the following Abs or reagents: FITC-anti-IgMa (DS-1; BD 
Biosciences), PE-anti-IgMb (AF6-78; BD Biosciences), Biotin-anti-CD23 (B3B4; BD 
Biosciences), PerCP/Cy5.5 anti-CD21/35 (7E9; BioLegend), and PE/Cy7-SA (BD 
Biosciences). Flow cytometry was conducted using an LSR-II flow cytometer (BD 
Biosciences) and data was analyzed using FlowJo 10. Surface IgM expression was 
assayed on singlet, live, B220+ cells. 
Flow cytometry for intracellular TCRβ allelic inclusion 
Surface stains were conducted using the following Abs or reagents from BD Biosciences: 
PE-anti-B220 (RA3-6B2), APC-anti-TCRβ (H57-597), V450-anti-CD4, TxRed-anti-CD8, . 
After surface staining, cells were permeabilized using BD Fix-Perm solution according to 
the manufacturer's instructions. After permeabilization cells were stained with 
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combinations of FITC or biotin conjugated: anti-Vb5 (MR9-4), anti-Vb14 (14-2), anti-Vb8 
(F23.1), anti-Vb4 (KT4), anti-Vb6 (RR4-7), anti-Vb12 (MR11-1), and PE/Cy7-streptavidin. 
Flow cytometry was conducted on an LSR-II flow cytometer (BD Biosciences) and data 
was analyzed with FlowJo 10. Internal Vβ expression was assayed on singlet, live, cells. 
Stimulation of αβ T cells for generation of hybridomas and for two-color fluorescence 
in situ hybridization assays 
Single-cell suspensions were isolated from the spleens of 6-wk-old mice and depleted of 
RBCs with NH4Cl lysis buffer prior to stimulation. Each spleen was stimulated for 48 h in 
40 U/ml IL-2 and 5 mg/ml Con A at 4 ml/spleen in DMEM containing 15% FBS, 1% 
penicillin/streptomycin, 1% L-glutamate, and 30 mM β-mercaptoethanol. Additional 
medium was added to the stimulation after 24 h. 
Two-color fluorescence in situ hybridization assay 
T cells stimulated for 48 h were arrested in metaphase by incubating with colcemid 
(KaryoMax) and 0.45 mM BrdU (Sigma-Aldrich) for 2 h. Metaphase-arrested cells were 
isolated by hypotonic treatment (40 mM KCl, 0.5 mM EDTA, and 20 mM HEPES [pH 7.4]) 
and fixation in methanol:acetic acid (3:1 volume). The fixed cells were dropped on slides 
at 4°C and dried at 75°C for 5 min. Metaphase spreads were hybridized overnight with 
Tcrb bacterial artificial chromosome probes Vb-DbJb1, RP23-203H5 and Cβ, 164G11. Cβ 
probe was labeled using  DIG-NICK Translation Mix (Roche). Vb-DbJb1 probe was labeled 
133 
 
using BioPrime DNA Labeling System (Invitrogen). Probes were detected using FITC-anti-
digoxin Fab (Roche) and Texas Red-streptavidin (Vector Laboratories). Coverslips were 
mounted with Vectasheild mounting medium with DAPI (Vector Laboratories). Images 
were captured and analyzed using Case Data Manager (Applied Spectral Imaging).  
Fusion and Analysis of T Cell Hybridomas 
αβ T cell hybridomas were produced by fusion of ConA and Il-2 stimulated T cells  
with BW-1100.129.237 thymomas. Southern analyses of Tcrβ rearrangements were 
performed as previously described (Khor and Sleckman, 2005). 
PCR Analysis and Sequencing of Vβ Rearrangements in Hybridomas 
Hybridoma genomic DNA was isolated and Vβ rearrangements were amplified by PCR 
using Vβ-specific primers and 3’Jβ1.2 primer (P2) as previously described (Bassing, Alt 
et al. 2000; Steinel, Brady et al. 2010). PCR products were resolved on a 1% agarose gel 
to identify which Vβs were utilized. PCR products were purified (Qiagen, QIAquick 
PCR Purification Kit, 28104) and sequenced using the 3’Jβ1.2 primer (P2). 
Statistical analyses 
All statistics were generated using GraphPad Prism 5 or Prism 7 software. 
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Table 1: qPCR primers 
18S F CGCGGTTCTATTTTGTTGGT 
18S R AGTCGGCATCGTTTATGGTC 
β actin F TCATCACTATTGGCAACGAGCGGTTC 
β actin R TACCACCAGACAGCACTGTGTTGGCA 
CD19 F ACCAGTACGGGAATGTGCTC 
CD19 R TTCATAGGCCTCCCCTTCTT 
Gadd45α F CCGAAAGGATGGACACGGTG 
Gadd45α R TTATCGGGGTCTACGTTGAGC 
Hprt F CTGGTGAAAAGGACCTCTCG 
Hprt R TGAAGTACTCATTGTAGTCAAGGGCA 
Lck F CCTTCGGGATCTTGCTTACA 
Lck R GTTGTCAGGTCTCACCATGC 
p21 F GACATTCAGAGCCACAGGCAC 
p21 R GTCAAAGTTCCACCGTTCTCG 
Rag1 F TGGGAATCGTTTCAAGAGTGAC 
Rag1 R CATCTGCCTTCACGTCGATCC 
Rag2 F ACACCAAACAATGAGCTTTCCG 
Rag2 R CCGTATCTGGGTTCAGGGAC 
Spic F AAACATTTCAAGACGCCATTGAC 
Spic R CTCTGACGTGAGGATAAGGGT 
Wasp F GCTCCCTCCTACTCCAGTGTC 
Wasp R AGGGCACCTACTAGGCCTTC 
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